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Background: Measurement can affect the people being measured; for example, asking people to complete
a questionnaire can result in changes in behaviour (the ‘question–behaviour effect’). The usual methods of
conduct and analysis of randomised controlled trials implicitly assume that the taking of measurements
has no effect on research participants. Changes in measured behaviour and other outcomes due to
measurement reactivity may therefore introduce bias in otherwise well-conducted randomised controlled
trials, yielding incorrect estimates of intervention effects, including underestimates.
Objectives: The main objectives were (1) to promote awareness of how and where taking
measurements can lead to bias and (2) to provide recommendations on how best to avoid or minimise
bias due to measurement reactivity in randomised controlled trials of interventions to improve health.
Methods: We conducted (1) a series of systematic and rapid reviews, (2) a Delphi study and
(3) an expert workshop. A protocol paper was published [Miles LM, Elbourne D, Farmer A, Gulliford M,
Locock L, McCambridge J, et al. Bias due to MEasurement Reactions In Trials to improve health
(MERIT): protocol for research to develop MRC guidance. Trials 2018;19:653]. An updated systematic
review examined whether or not measuring participants had an effect on participants’ health-related
behaviours relative to no-measurement controls. Three new rapid systematic reviews were conducted
to identify (1) existing guidance on measurement reactivity, (2) existing systematic reviews of studies
that have quantified the effects of measurement on outcomes relating to behaviour and affective
outcomes and (3) experimental studies that have investigated the effects of exposure to objective
measurements of behaviour on health-related behaviour. The views of 40 experts defined the scope
of the recommendations in two waves of data collection during the Delphi procedure. A workshop
aimed to produce a set of recommendations that were formed in discussion in groups.
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Results: Systematic reviews – we identified a total of 43 studies that compared interview or
questionnaire measurement with no measurement and these had an overall small effect (standardised
mean difference 0.06, 95% confidence interval 0.02 to 0.09; n = 104,096, I2 = 54%). The three rapid
systematic reviews identified no existing guidance on measurement reactivity, but we did identify
five systematic reviews that quantified the effects of measurement on outcomes (all focused on the
question–behaviour effect, with all standardised mean differences in the range of 0.09—0.28) and
16 studies that examined reactive effects of objective measurement of behaviour, with most evidence
of reactivity of small effect and short duration. Delphi procedure – substantial agreement was reached
on the scope of the present recommendations. Workshop – 14 recommendations and three main aims
were produced. The aims were to identify whether or not bias is likely to be a problem for a trial, to
decide whether or not to collect further quantitative or qualitative data to inform decisions about if
bias is likely to be a problem, and to identify how to design trials to minimise the likelihood of this bias.
Limitation: The main limitation was the shortage of high-quality evidence regarding the extent of
measurement reactivity, with some notable exceptions, and the circumstances that are likely to bring
it about.
Conclusion: We hope that these recommendations will be used to develop new trials that are less
likely to be at risk of bias.
Future work: The greatest need is to increase the number of high-quality primary studies regarding
the extent of measurement reactivity.
Study registration: The first systematic review in this study is registered as PROSPERO
CRD42018102511.
Funding: Funded by the Medical Research Council UK and the National Institute for Health Research
as part of the Medical Research Council–National Institute for Health Research Methodology
Research Programme.
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Behaviour change technique A systematic procedure included as an active component of an
intervention designed to change behaviour.
Bias Systematic deviation of results or inferences, leading to results or conclusions that are
systematically (as opposed to randomly) different.
Logic model A graphic that represents the theory of how an intervention produces its outcomes.
It represents, in a simplified way, a hypothesis or ‘theory of change’ about how an intervention works.
Measurement reactivity The response of a study participant to the act of being measured. It can take
the form of a change in behaviour, emotions or self-provided data.
Question–behaviour effect When the act of asking questions about behaviour produces changes in
the behaviour being asked about.
Study within a trial A self-contained research study that has been embedded within a host trial with
the aim of evaluating or exploring alternative ways of delivering or organising a particular trial process.
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AMSTAR 2 A MeaSurement Tool to Assess
systematic Reviews version 2
BCT behaviour change technique
CI confidence interval
CONSORT Consolidated Standards of
Reporting Trials
MERIT MEasurement Reactions In Trials
MR measurement reactivity
MRC Medical Research Council
NIHR National Institute for Health
Research
QBE question–behaviour effect
RCT randomised controlled trial
SOP standard operating procedure
SWAT study within a trial
TPB theory of planned behaviour
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When people are asked to complete measures such as questionnaires in research studies this canproduce changes in the behaviour or emotions of those people. For example, people who are
asked to complete questionnaires about drinking alcohol have been found to drink slightly less, on
average, than people who are not asked to complete questionnaires. Current established methods of
research usually ignore these reactions to measurement.
The present research aimed to produce recommendations for how best to deal with reactions to
measurement. The scope of these recommendations was limited to ‘trials’ used to test whether or not a
treatment improves health.
To do this, we identified relevant research studies that have investigated various different aspects of
whether or not measurement affects the people being measured. We then consulted 40 experts about
what the current recommendations should consider and what was not within the scope of the current
recommendations.
We then gathered 23 experts together for 2 days to produce a set of recommendations.
We found 43 research studies that have looked at whether or not being asked to complete
questionnaires or being interviewed affects the behaviour of those people invited. In general,
there were some effects of completing questionnaires, but the effects were not very consistent
across research studies. There were few studies that have looked at the effects of using measures
of behaviour other than questionnaires (e.g. blood pressure cuffs). We could find no existing
recommendations for how best to deal with reactions to measurement in research studies that
examine whether or not treatments improve health.
We have produced 14 recommendations for researchers to better take account of the issue of
measuring affecting the people being measured. We hope that this will help future research produce
more accurate answers. We also identified that there is a need for more studies of the effects of
measures other than questionnaires.
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Measuring people can affect their behaviour, their emotions and the data they provide about themselves.
This phenomenon is known as measurement reactivity. Randomised controlled trials always include
measurements of trial outcomes and commonly include further measurements as part of process
evaluations. The usual methods of conduct and analysis of trials implicitly assume that the taking of
measurements does not affect subsequent outcome measurements or interact with the trial intervention
and that any effects of measurement-taking will be the same in each experimental group and, hence,
are unlikely to bias treatment comparisons. The present report aims to promote awareness of how and
when taking measurements can lead to bias and to provide recommendations to prevent such bias.
There are few areas of research where there is sufficient evidence to be entirely confident that
measurement reactivity is present. The most compelling evidence of measurement reactivity is
found in two areas: (1) the question–behaviour effect (i.e. when the act of asking questions about
behaviour produces small changes in the behaviour being asked about) and (2) the use of pedometers
(particularly where step counts can be read by participants) leading to increases in physical activity.
Other measurement procedures widely employed for outcome evaluation in randomised controlled
trials, such as assessing body weight, are also used as intervention techniques in their own right
because they are seen to be effective at producing behaviour change. It is not clear whether the
limitations of the evidence base are due to a genuine lack of effect of measurement on outcomes
or a lack of research to examine the effects of measurement on outcomes.
There is little direct evidence regarding how much of a problem measurement reactivity poses for
bias in trials. As a consequence, measurement reactivity has generally been ignored in discussions of
how to reduce bias in trials. Measurement reactivity is therefore not adequately addressed in existing
guidelines for designing, reporting and appraising trials.
Objective
The MEasurement Reactions In Trials (MERIT) study aimed to produce recommendations to minimise
risk of bias from measurement in trials of interventions to improve health.
Methods
The MERIT study consisted of (1) a series of systematic and rapid reviews, (2) a Delphi study and
(3) an expert workshop to develop recommendations on how to minimise bias in trials due to
measurement reactivity.
An updated systematic review examined if measuring participants had an effect on participants’
health-related behaviours relative to no-measurement controls. Three new rapid systematic reviews
were conducted to identify:
1. existing guidance on measurement reactivity
2. existing systematic reviews of studies that have quantified the effects of measurement on outcomes
relating to behaviour and affective outcomes
3. studies that have investigated the effects of objective measurements of behaviour on health-
related behaviour.
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The views of 40 experts were sought to identify the scope of the recommendations in two rounds of a
Delphi consultation. A workshop in October 2018 involved discussion of potential recommendations
by 23 experts. Recommendations were formed through discussion in groups, with no formal voting
procedure to indicate consensus being required.
Recommendations
The MERIT study has produced recommendations for reducing the risk of bias from measurement,
with a focus on balancing measurement reactivity concerns in the context of wider trial design decision-
making, including attending to established sources of bias. Development of the recommendations has
relied extensively on indirect evidence, which is contingent on reasonable inference regarding the
likely consequences of measurement in producing bias. Given the limited direct evidence, many of the
recommendations are – in the terminology of the Grading of Recommendations Assessment, Development
and Evaluations (GRADE) – ‘motherhood statements’, in that to recommend the opposite would not
be reasonable.
We propose that researchers consider the following issues in relation to measurement reactivity as a
potential source of bias. The recommendations also includes a list of randomised controlled trial features
that should act as ‘red flags’ and indicate when risk of bias due to measurement reactivity may be present.
The 14 recommendations are as follows:
1. Consider the potential for measurement reactivity causing bias at the design stage of a trial.
2. Consider the potential for measurement reactivity as a source of bias throughout the
research process.
3. Consider specific trial features that may indicate heightened risk of bias due to
measurement reactivity.
4. Theorise potential measurement reactions as part of a logic model of how an intervention is
intended to work.
5. Consider the burden of measurement procedures and potential impact on participants in
comparison with the intensity and duration of the studied intervention.
6. Consider how participants may use measurement in trials to meet their own aims.
7. Consider whether or not measurement reactivity concerns for the trial warrant further
empirical examination.
8. Examine feedback from research personnel regarding research participants’ reports of changes in
their behaviour/thoughts/emotions as a result of measurement.
9. Consider possible measurement reactivity when determining the overall burden of measurement in
a trial.
10. Embed measurement procedures onto routine clinical practice when possible.
11. Use identical measurement protocols in all arms of a trial.
12. Avoid overlap between measurement and intervention.
13. Consider the potential benefits of masking measures and/or withholding feedback of measured
values against ethical considerations.
14. If measurement reactivity is likely to be present, investigations for measurement reactivity should
be included a priori in the statistical analysis plan.
Research priorities
A major limitation of the evidence base used to develop the recommendations is the shortage of
good-quality studies that have estimated the extent and magnitude of measurement reactivity
in different settings. Accordingly, we identify the following research priorities to develop a
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stronger evidence basis for future consideration of the nature and extent of bias in trials due to
measurement reactivity:
l more primary research to quantify extent of measurement reactivity
l research priorities for studies within a trial to further understanding of measurement reactivity
¢ conduct further empirical studies to provide more compelling evidence on study features that
indicate that measurement may be particularly reactive
¢ compare traditional, obtrusive research methods with unobtrusive research methods
¢ examine effects of measurement on both objective and subjective outcomes
l more systematic reviewing to quantify extent and variability of measurement reactivity
l better theorise when and why measurement reactivity is likely to occur.
We hope that this practical help on measurement reactions in trials will raise awareness of the ways
in which trial evidence can be undermined by measurement reactivity and how this can be prevented
and advance consideration of how measurement reactivity might be better understood in the future.
Our ultimate aim is that these recommendations will be used in designing future trials so that trials are
less likely to be at risk of bias.
Study registration
The first systematic review in this study is registered as PROSPERO CRD42018102511.
Funding
Funded by the Medical Research Council UK and the National Institute for Health Research as
part of the Medical Research Council–National Institute for Health Research Methodology
Research Programme.
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Measuring people can affect their behaviour, their emotions and the data that they provideabout themselves.1–3 This phenomenon is sometimes known as measurement reactivity (MR).1
Randomised controlled trials (RCTs) always include measurements of trial outcomes and commonly
include further measurements as part of process evaluations. Measurements include self-reports
(e.g. via questionnaires and interviews), objective measurements of behaviour (e.g. via accelerometers)
and clinical markers (e.g. blood pressure or body scans that estimate body fat). Measurement techniques
used in trials are typically treated as though they are inert (i.e. have no impact on participants). The usual
methods of conduct and analysis of trials implicitly assume that the taking of measurements does not
affect subsequent outcome measurements or interact with the trial intervention and that any effects
of measurement-taking will be the same in each experimental group and, hence, are unlikely to bias
treatment comparisons.1,2,4 Any effects on participants are therefore ignored and not considered as
a potential source of bias in trials (i.e. incorrect estimates of intervention effects or their standard
errors). The present report aims to promote awareness of when trial measurements can produce bias
and to provide recommendations to prevent such bias.
The phenomenon of MR is related to the broader term ‘Hawthorne effect’,5 which is used to refer to
research participants changing their behaviour in response to being observed. The Hawthorne effect
appeared in a research publication 65 years ago5 and the term is in widespread use, although it has
been the subject of little empirical research.6 It has been suggested that the Hawthorne effect is an
umbrella term for a number of discrete phenomena, including MR, and it is proposed that more precise
terms are needed to develop understanding of research participation effects and how they may lead to
bias.7 In the present document, the term MR is used to mean changes (in individual trial participants as
well as in others such as health-care professionals) that would not occur in the absence of measurement.
There are few areas of research where there is sufficient evidence to be entirely confident that MR is
present. The main exceptions are (1) the question–behaviour effect (QBE)3,8–11 and (2) pedometers.12,13
The evidence in both of these areas is summarised in Boxes 1 and 2. In addition, there is evidence from
randomised studies showing that people who complete questionnaires about the consequences of health
conditions have higher anxiety levels than people who have not completed such questionnaires.18,19
Furthermore, when people complete questionnaires about anxiety for the first time, they score more
highly than when they are measured subsequently.18,20,21 Other measurement procedures widely
employed to assess outcomes in RCTs (e.g. assessing body weight) are also used as intervention
techniques in their own right because they are seen to be effective at producing behaviour change.22
BOX 1 Question–behaviour effect
Several systematic reviews, including a meta-analytic synthesis of 104 question–behaviour studies
across 51 published and unpublished papers, found evidence that measuring a variety of behaviours via
questionnaires can affect the subsequent performance of those behaviours.3,8–11 Much of this evidence
derives from studies in which people who were asked to complete a questionnaire about their behaviour, or
attitudes or beliefs about that behaviour, showed changes in that behaviour relative to a no-questionnaire
control group. Systematic reviews have consistently provided evidence of small effects on objective and
subjective measures of behaviour, but there is considerable heterogeneity in the effects. Individual primary
studies in the reviews have generally shown that some risk of bias and publication bias may be present,
although it does not appear that bias can fully account for the effects observed.8,9,14
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The present report considers the challenges associated with MR for all kinds of RCTs, especially in the
context of behaviour change, public health and health services research.2 The focus on trials is because of
the central importance of trials evidence for health-care decision-making. The present recommendations
are designed to apply when measurement is used as a method of assessment that produces unintended
effects rather than when it has been used as an intended intervention. The report is structured as follows.
In summary, there are multiple and diverse empirical studies showing that measurement may produce
changes in the people being measured. By contrast, there is little direct evidence regarding how much of a
problem MR poses for bias in trials because there has been little research directly addressing this issue.4,23
As a consequence, MR has generally been ignored in discussions of how to reduce bias in trials. Given this,
MR is not adequately addressed in existing guidelines for designing, reporting [e.g. Consolidated Standards
of Reporting Trials (CONSORT)24] and appraising trials (e.g. risk-of-bias frameworks).25 In the present
document we rely on indirect evidence regarding the likely consequences of measurement in producing
bias. That is, drawing on the existing evidence regarding where measurement affects research participants,
we have produced scenarios where we think it plausible that bias may be produced. The procedure
by which these recommendations were developed is described in more detail in Chapter 3, involving
systematic reviewing and consultation with experts as part of the MEasurement Reactions In Trials
(MERIT) study. It should be noted that, given the limited direct evidence, many of the recommendations
are – in the terminology of the Grading of Recommendations Assessment, Development and Evaluations
(GRADE) – ‘motherhood statements’, in that to propose the opposite would not be reasonable.26
In Chapter 2 we spell out how measurement affecting people can produce bias.
In Chapters 3 and 4 we discuss some issues for researchers to consider in relation to MR as a potential
source of bias. We include a list of RCT features that should act as ‘red flags’ for researchers to consider
as indicating that MR or risk of bias due to MR may be present.
In Chapter 5 we identify future research that is needed to develop a stronger evidence base on the
extent of bias in trials due to MR.
BOX 2 Measurement reactivity from use of pedometers
A systematic review of eight RCTs and 18 observational studies found that providing people with pedometers
produced an increase in physical activity, particularly when pedometers are provided in conjunction with
goal-setting12 and when research participants can access step count readings.13 Given this, pedometers are
sometimes used as part of interventions15 and are often used as tools to measure outcomes. These two
purposes for which pedometers are being used has flagged up that measurement is not always inert in trials
and that greater consideration is needed for pedometers when used solely as measurement tools.
Although use of pedometers can produce changes in people’s behaviour, it is unclear to what extent their
use causes bias in trials; however, there are plausible reasons to think that it does. The mechanism by
which the provision of pedometers produces an increase in physical activity is that pedometers allow
participants to self-monitor their behaviour.1,16 The use of self-monitoring is a key component of many
behaviour change interventions.17 Therefore, the use of pedometers as a measurement tool could result in
both trial arms receiving assistance in self-monitoring their behaviour when this was intended in only one
arm. This would be likely to reduce the observed effect of an intervention that was designed to promote
self-monitoring to increase physical activity, relative to the true effect that would be observed without the
use of pedometers.
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The main aims of the present recommendations are to help researchers more systematically consider
MR as a potential threat to the validity of trial decision-making and to select appropriate strategies to
minimise this potential bias. We aim to highlight the current state of evidence regarding the extent of
MR and how it can lead to bias so that researchers can select strategies that are proportionate and
mindful of the many other forms of bias that need to be prevented in trials. Finally, we hope to raise
awareness of the ways in which trial evidence can be affected by MR and how MR might be better
understood in the future.
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Chapter 2 Measurement reactivity and
risk of bias
Parts of this chapter have been reproduced with permission from French et al.27 This is an OpenAccess article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: https://creativecommons.org/
licenses/by/4.0/. The text below includes minor additions and formatting changes to the original text.
This section is concerned with describing mechanisms by which MR can lead to bias. Bias has been
defined as ‘systematic deviation of results or inferences . . . leading to results or conclusions that are
systematically (as opposed to randomly) different’.28 It is important to note that MR may or may not lead
to bias in trials: the existence of MR in a trial does not necessarily mean that the intervention effect
estimate is biased.We describe six scenarios in which MR may produce bias. These may seem in some
ways closely related to each other, although they are conceptually distinct, with bias being produced via
different mechanisms in each scenario. Being aware of the distinctions between them should help
develop understanding of the nature of MR and the associated bias. The six scenarios are:
1. different measurement protocols across trial arms
2. contamination
3. interactions between measurement and intervention
4. dilution bias
5. other inadvertent intervention effects
6. effects on other forms of bias such as attrition or information bias.
Different measurement protocols across trial arms
Bias may arise when different measurement protocols are used across randomised trial arms, with
one trial arm being measured more than, or differently from, another. If measurement has an impact
on trial outcomes, then greater disparities in measurement protocols will produce greater bias. For
example, participants in the experimental condition may be asked to complete process measures to
assess mechanism, more frequent momentary assessments of behaviour or treatment response and/or
ongoing measurements using technology (e.g. a digital application), whereas participants in the control
condition are not asked to complete such measures. Such practices may be found widely in eHealth,
mental health and other areas in which psychosocial and behaviour change interventions are evaluated.
Ongoing measurements, for example for fidelity assessment or intervention development feedback
purposes, carry the potential to serve as reinforcers, reminders or boosters of intervention effects, and
thus can exaggerate the apparent effects of interventions. This entails bias when these measurements
are not defined as part of the intervention to be assessed.
Contamination
Contamination refers to the inadvertent exposure of a non-experimental control group to intervention
content that is an integral part of an effective experimental group treatment. For instance, if a pedometer
were one component of a multicomponent intervention to promote walking, then its use as a research
measure is intrinsically problematic because the non-intervention control group also has access to part
of the intervention. If the intervention component in question is actually inert (i.e. it is not effective in
producing change in measured outcomes), then bias would not result. It will often be the case that it is
unknown whether or not a particular component will produce change, and so vigilance should be exercised
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when intervention content and outcome assessment are closely related. Similarities between the contents
of research measurements and interventions also provide prima facie grounds for concern about bias
being induced by contamination. This is because they may exert their effects via similar or the same
mechanisms. In this situation, estimates of effectiveness are likely to be biased towards the null because
both intervention and control groups are exposed to similar content.
Interactions between measurement and intervention
If MR is present, then the risk of bias needs to be considered. Research measurements and
interventions, even when they are very distinct and there is no overlap in content, may exert their
effects via similar mechanisms. For example, pedometers may be effective intervention tools because
they produce effects by promoting self-monitoring of behaviour. Thus, research procedures other
than pedometers (e.g. regular body weight weighing) that also stimulate participant self-monitoring
may interfere with comparisons between randomised groups. That is, although the intervention tool
(i.e. pedometers) and measurement tool (i.e. weighing) take different formats, they both may promote
self-monitoring and hence the control group may be exposed to content that underpins the anticipated
effect of the intervention. In this example the biasing effect will be similar to that of contamination
(i.e. towards the null). There are other circumstances in which it goes in the opposite direction.
This scenario illustrates a wider point about how randomisation may not always safeguard against
bias due to MR, making it difficult to distinguish true change in outcomes arising from the intervention
from change due to a combination of intervention and measurement.4 This is true even in the absence
of contamination. If there are similar levels of reactivity between experimental groups in a trial, it
might be considered that the true effects of interventions are safeguarded by randomisation, but this
does not take into account the possibility that measurements might interact with interventions to
either strengthen or weaken the observed effects and, therefore, lead to biased estimates of effect
(see Appendix 2). For example, research measurement could prepare experimental group participants
to be more receptive to an intervention by prompting contemplation of the reasons for behaviour
change.4 Similarly, measurement may also obstruct or diminish the means by which interventions
produce their effects (e.g. if it creates or reinforces negative views towards the intervention target).
These examples suggest interaction effects between measurement and intervention on trial outcomes.
When measurement invites thinking about barriers to successfully performing physical activity (e.g.
resulting in problem-solving on the part of the participant) and when barriers to anticipation and
problem-solving are not an intended part of the intervention, it would be surprising if this had no
relevance to the effects of the intervention. Alternatively, a food diary may draw attention to the
elements of a dietary intervention that are being tested in the experimental arm and, therefore, enhance
the effects of intervention components. Such interactions between measurement and intervention could
be widespread in the case of interventions whose effects rely on behaviour change, but this possibility
has received little empirical attention.
Dilution bias
Dilution bias refers to the situation in which MR has an impact on both arms in a two-arm trial and
interferes with the estimation of effect sizes through restrictions on the possible range of measured
outcomes.4 For example, there may be a finite limit to the distance walked that a walking intervention
can reasonably stimulate. The more pedometers or other measurement procedures unintentionally
stimulate the behaviour that is the target of the intervention, the less scope there is for the intervention
to be more effective than the control. This situation will also arise for other behaviours or targets for
health interventions that are susceptible to measurement reactions. Consideration of the likely
maximum effects on the extent of change possible following intervention is therefore needed to
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appreciate this particular risk of bias. When measurement reactions account for change and there are
finite limits to how much change is possible, MR may lead to dilution bias, making it less likely that
intervention effects will be identified.4
Other inadvertent intervention effects
There are both clinical and research practices associated with measurement that can lead to bias
when MR is present. Sharing measurement data that are surprising or that can have an impact in other
ways could prima facie be regarded as particularly likely to be produce reactions to measurement. For
example, the process of collecting measurement data taken during the course of a trial may alter the
care provided by health-care professionals, which may lead to bias if such alterations are implemented
differently for different randomised groups. This may happen when one group of patients have
more frequent contact with health-care professionals (e.g. through regular assessment of body weight,
blood pressure or blood tests to assess liver function). This is a specific case of the wider class of
performance bias.29 Both experimental and control groups can be exposed to inadvertent intervention
effects in this way, making it possible that the direction of the bias could go either way.
Effects on other forms of bias such as attrition or information bias
Reactions to measurement can take many forms. They can also be implicated in other well-known
forms of bias in addition to those discussed above. For example, from the participant’s perspective,
too much measurement can increase the burden of trial participation so that they decide to drop out.
Measurement content lacking in salience can also produce such reactions.30 In principle, there should
be no bias when such effects are equivalent between randomised groups. The potential for them to
interact with randomisation status becomes clearer in situations in which there are already differences
in participant burden between randomised arms due to intervention exposure. When interventions are
somewhat onerous and the burden quite different for control group participants, MR may be more
likely to produce differential attrition.
Measurement reactivity may also be implicated in information bias, particularly when trial outcomes
are self-reported and measurement leads participants, for whatever reason, to inaccurately report data
about themselves. This may be a problem particularly for socially undesirable behaviours.31 Again, for
bias to be introduced to intervention effect estimates in trials, the effects of biased reporting need to
be differential between randomised arms. So the question becomes ‘How likely is it that intervention
content has any impact on the likelihood of biased reporting?’. When the intervention concerns the
socially undesirable behaviour, this seems very likely.
Summary
In this chapter we have made a series of subtle distinctions between different forms of bias and how
they may be induced by MR. In scenarios 1 and 2, it is the main effects of MR that can lead to bias,
whereas in the other scenarios (i.e. scenarios 3–6) the mechanisms are more complex and involve
interactions with other aspects of the study design. In scenarios 1 and 3, the effects of MR are
different between randomised arms. The implication here is that MR has undermined equivalence
between randomised groups. In scenarios 2 and 4, MR may lead to bias by thwarting the intended
experimental contrast. In the last two scenarios (i.e. scenarios 5 and 6), MR may also generate bias
through established forms of bias (e.g. performance bias) that are not usually thought of in the context
of MR. Specific recommendations about how to detect MR, investigate further for its presence and
deal with MR when it appears to be an important source of risk of bias is covered in the next chapter.
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Chapter 3 Research informing the development
of recommendations
The present research used a variety of methods to produce recommendations to minimise risk ofbias from MR in trials of interventions to improve health. Specifically, we conducted (1) a series of
systematic and rapid reviews, (2) a Delphi study and (3) an expert workshop to develop recommendations
on how to minimise bias in trials due to MR. The study protocol has been published.2 The present chapter
describes the methods employed in each of these elements, which are summarised in Figure 1.
The team conducting the MERIT project was led by Professor David French (University of Manchester)
and consisted of Dr Lisa Miles (University of Manchester), Professor Diana Elbourne (London School
of Hygiene and Tropical Medicine), Professor Andrew Farmer (University of Oxford), Professor
Martin Gulliford (King’s College London), Professor Louise Locock (University of Aberdeen), Professor
Jim McCambridge (University of York) and Professor Stephen Sutton (University of Cambridge). The
team was formed with the intention of providing a wide variety of expertise relevant to the formation
of recommendations on this topic.
We planned to involve the public, including patients and service users, as one of the key stakeholders
in the present research in the Delphi process (described in Delphi procedure to inform the scope of the
recommendations). However, despite approaching a number of people who have fulfilled these roles in
other research that the team have been involved in, we were not successful in recruiting anyone in the
time available. It may be that the present research, which involves conducting research on the research
process, is less appealing to non-specialists, even those with considerable experience in patient and
public involvement.
What were the views of key stakeholders
on the scope of the recommendations to
be produced?
What was the current state of key literature on
MR and its contribution to bias?
An updated systematic review examined
whether or not measuring participants using
questionnaires or interviews had effects on 
health-related behaviours relative to
no-measurement controls
Delphi procedure: the views of expert
stakeholders were sought to identify the
scope of the recommendations in two
waves of data collection
Three new rapid systematic reviews to identify:
• existing systematic reviews of studies that
    have quantified the effects of measurement on
    outcomes relating to behaviour and affective
    outcomes
• studies that have investigated the effects 
    of objective measurements of behaviour on 
    health-related behaviour
• existing guidance on MR
An expert workshop was held in October 2018 to produce a set recommendations, formed 
through discussion in groups, with no formal voting procedure to indicate consensus being required
FIGURE 1 Overview of research activities in the MERIT study that informed the development of the recommendations.
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Asking questions changes health-related behaviour: an updated systematic
review and meta-analysis of randomised controlled trials
Objective
An existing systematic review on the QBE on health-related behaviours9 found that asking people
questions can result in changes in behaviour. However, the overall effect was small, with many of the
included studies at high risk of bias, and publication bias was also detected. A lack of pre-registration
of these studies was a particular issue because many of these studies included consideration of the
QBE as part of other studies, leading to a concern that, if no QBE was found, then the findings in
relation to the QBE were not published. Subsequent to the search for this systematic review, which
was conducted in 2012, larger studies with pre-registered protocols have been published,32,33 with
generally null findings. For this reason, it seemed timely to update this systematic review to inform
the MERIT study. As with the original review, this review included RCTs investigating the QBE.
Study design and methods
A systematic search for newly published trials covered January 2012 to July 2018. Eligible trials randomly
allocated participants to measurement conditions, to non-measurement control conditions or to different
forms of measurement conditions. Studies that reported health-related behaviour as outcomes were
included and meta-analysis was performed. Subgroup analyses were conducted to assess the impact of
potential prespecified moderators of the QBE and sensitivity analyses were conducted to assess whether
or not there were differences in QBE on the basis of risk of bias or presence of a pre-registered protocol.
Results
Forty-three studies (33 studies from the original systematic review and 10 new studies) compared
measurement with no measurement. An overall small effect was found using a random-effects model
[standardised mean difference 0.06, 95% confidence interval (CI) 0.02 to 0.09; n= 104,388]. Statistical
heterogeneity was substantial (I2= 54%). In an analysis restricted to studies with a low risk of bias, the
QBE remained small but significant. Sensitivity analyses indicate that there was still substantial unexplained
variance, probably due to large variation in studies with respect to content of measurement, types of
health-related outcomes, length of follow-up and characteristics of participants. Subgroup analyses
suggested that the QBE was present for some health-related behaviours more than others. There was
positive evidence of publication bias.
Conclusion
This update shows a small but significant QBE in trials with health-related outcomes, but with
considerable unexplained heterogeneity. Future trials with lower risk of bias, pre-registered protocols
and greater attention to blinding are needed.
Note on publication
The systematic review update on the QBE has been published.34
Further evidence reviews to inform development of the recommendations
Three new rapid reviews were conducted to identify (1) systematic reviews of studies that have
quantified the effects of measurement on outcomes relating to behaviour and affective outcomes in
health and non-health contexts, (2) studies that have investigated the effects of objective measurements
of behaviour on concurrent or subsequent behaviour itself and (3) existing guidance on MR.
Rapid ‘review of reviews’ of studies of measurement reactivity
This review aimed to identify existing systematic reviews of studies that have quantified the effects of
measurement on outcomes relating to behaviour and affective outcomes in both health and non-health
contexts to identify relevant background literature for the MERIT study.
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Reviews that provide a quantitative estimate of a measurement effect are briefly described in terms
of their aims, scope, methods, quality, findings and conclusions. A detailed critique of each review is
not provided, but important limitations that affect the validity of the conclusions are mentioned.
Methods
The following databases were searched, limited to English-language articles published in peer-reviewed
journals between 2008 and 2018 (inclusive): PsycINFO, MEDLINE, PubMed and the Cochrane
Database of Systematic Reviews. Search terms were developed and tested to check that they
identified reviews that were already known to the research team. The final search strategy is given
in Appendix 3. Two searches were run for each database: (1) a general search to identify relevant
systematic reviews and meta-analyses and (2) a more specific search for reviews and meta-analyses
of the QBE or mere measurement effect. The searches were limited to the titles and abstracts of the
papers in the above databases. The reference lists of identified reviews were searched manually for
additional relevant reviews.
Titles and abstracts of identified records were screened by one reviewer. Full-text versions of relevant
articles were obtained and screened by the same reviewer. No data extraction form was used. Relevant
study characteristics and data from the final set of reviews were extracted directly to tables and text
in this report. Included reviews were rated for quality by the same reviewer, using A MeaSurement
Tool to Assess systematic Reviews version 2 (AMSTAR 2).35
A search of PROSPERO using the search terms in Appendix 3 identified two reviews9,11 that had already
been published, but no ongoing reviews.
Results
The searches of PsycINFO, PubMed and the Cochrane Database of Systematic Reviews yielded 1728
records. One additional record was identified from manually searching the reference lists of identified
reviews. Twenty-one full-text articles were screened. Sixteen of these articles were excluded, in most
cases because they did not directly address the topic of MR or they were narrative reviews or discussion
papers on reactivity.1,36–43 Several of these articles addressed reactivity of assessment of alcohol use
(e.g. in the context of alcohol brief interventions).6,36–40,42,44–52 One article37 discussed assessment
reactivity in studies of interventions for intimate partner violence. However, none of these reviews
reported a quantitative estimate of MR and these were therefore excluded from the present review.
A flow diagram showing the search and screening process is shown in Figure 2.
The searches failed to identify the review by McCambridge et al.23 of evidence from Solomon
four-group studies. An additional search was therefore run for reviews of studies using the Solomon
design, but none was identified. The paper by McCambridge and Kypri8 was also not identified in
the searches; however, the paper is clearly relevant because it includes an effect size estimate. It is
therefore included in this review for the sake of completeness, although it differs in focus from the
other included reviews.
The five quantitative reviews3,9–11,53 that were identified in the searches all focused on the QBE. These
are described in turn. The first four reviews analysed studies that included a relevant comparison or
control group (Rodrigues et al.,9 Spangenberg et al.,3 Wood et al.10 and Wilding et al.11) and the fifth
(Mankarious and Kothe53) analysed prospective studies of the theory of planned behaviour (TPB).54
The four reviews3,9–11 of the QBE that included studies with a relevant comparison or control group used
broadly similar systematic review and meta-analytic methods but differed in terms of scope (type of
behaviour), research designs included (RCT only vs. RCT plus non-RCT designs), type of questioning and
potential moderators investigated. The headline effect size estimates are given in Table 1. The overlap
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between the four reviews3,9–11 in terms of included studies is shown in the Venn diagram in Appendix 4
(see Figure 4). A total of 94 studies were included in the reviews (see Appendix 4). Only nine of these
studies were included in all four reviews3,9–11 and significant numbers of studies were included in only
one review (e.g. 17 studies in Wilding et al.11 and 16 studies in Spangenberg et al.3) (see Figure 4).
Rodrigues et al.
Rodrigues et al.9 meta-analysed data from 41 RCTs of the QBE in the domain of health-related
behaviours. The authors found a small overall QBE (Cohen’s d = 0.09, 95% CI 0.04 to 0.13). Studies
showed variable risk of bias and evidence of publication bias (studies with smaller or no effects were
less likely to be published). No significant moderators of the effect were identified. There were no
significant differences in QBE by type of behaviour, but QBEs for three behaviours (i.e. dental flossing,
physical activity and screening attendance) were significantly different from zero. The authors conclude
that the observed small effect size may be an overestimate of the true effect and note that in some
TABLE 1 Summary of effect size estimates from four recent reviews of the QBE
Review Number of studies Cohen’s d 95% CI
Rodrigues et al.9 33 0.09 0.04 to 0.13
Spangenberg et al.3 104 0.28 0.24 to 0.32
Wood et al.10 116 0.24 0.18 to 0.30
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FIGURE 2 Flow diagram of search and screening process. a, It was more efficient to screen the records for each
database separately without identifying duplicates across databases.
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studies participants received intervention techniques in addition to questionnaires (e.g. thank you
letters). They recommend that future studies should be pre-registered.
Spangenberg et al.
Spangenberg et al.3 synthesised findings from 104 QBE studies from 51 published and unpublished
studies; all were randomised studies with a control condition in which participants responded to a neutral
control question or no question. There was no restriction on the types of behaviour included. The overall
weighted mean effect size (product–moment correlation) was r = 0.137 (95% CI 0.115 to 0.158; equivalent
to Cohen’s d = 0.28, 95% CI 0.24 to 0.32). The authors conclude that ‘Our results clearly support that
questioning people about a target behaviour is a relatively simple yet robust influence technique producing
consistent, significant changes in behaviour across a wide set of behavioural domains’.3 However, the main
aim of the study was to examine a number of prespecified potential moderating variables relating to four
different theoretical mechanisms (i.e. attitudes, consistency, fluency and motivations) proposed to underlie
the QBE. The authors found some support for each of the four mechanisms and suggest that there may be
multiple mediating processes. Significant moderator analyses showed larger effects for computer surveys
(compared with paper and pencil, telephone, individual mailers and face-to-face interviews), prediction
questions (compared with intentions or expectations), not specifying a time frame in the question when
the question required a dichotomous response (compared with continuous or multinomial responses),
behaviours related to participants’ personal welfare (compared with behaviours related to social welfare,
consumption or other types of behaviours), behaviours measured by self-report, novelty of behaviour, and
psychological and social risks associated with not performing the target behaviour.
Wood et al.
Wood et al.10 meta-analysed 55 studies of the QBE. There was no restriction on the type of behaviour.
Studies had to include an appropriate comparison control condition, but it is not clear if only randomised
studies were included. The overall effect size from 116 tests of the QBE was a Cohen’s d of 0.24 (95% CI
0.18 to 0.30).
Like Spangenberg et al.,3 this meta-analysis focused on potential moderators that may inform possible
mediating mechanisms. Univariate moderator analyses showed larger QBEs for greater attitude
accessibility; lower ease of representation; asking prediction or expectation questions (compared
with mixed items or intention items only); not asking anticipated regret questions; health, consumer
or other behaviours (compared with prosocial and risky or undesirable behaviours); more socially
desirable behaviours; less difficult behaviours; smaller time intervals between questioning and
behaviour measurement; laboratory-based studies (compared with field studies); providing an
incentive to respond; and student samples (compared with mixed, unreported or non-student samples).
The authors interpret these results as showing little support for any of the proposed explanations of
the QBE.
Wilding et al.
In the most recent meta-analysis of the QBE, Wilding et al.11 included 65 papers reporting 94 tests.
The authors note that this is between 12 and 30 papers more than previous meta-analyses. The
authors included non-RCT designs as well as RCTs. Overall, the meta-analysis yielded a small but
significant effect size (Cohen’s d = 0.15, 95% CI 0.11 to 0.19).
Moderator analyses showed larger effects for student samples; laboratory settings; question type that
was self-prediction or intention; specific behaviours (especially flossing, health assessment and risky
driving); desirable health behaviours; behaviours not measured at baseline; studies in which baseline
questioning was carried out face to face; studies that included a per-protocol analysis (compared with
an intention-to-treat analysis); when the research design was a non-RCT; shorter follow-up periods;
and studies at high or unclear risk of bias (compared with low).
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Mankarious and Kothe
Mankarious and Kothe53 conducted a meta-analysis of 66 TPB studies that measured health behaviours
at two or more time points. These were prospective observational studies and not RCTs, as in the other
quantitative reviews of the QBE. They calculated Cohen’s d to estimate the standardised mean difference
for behaviour from baseline to the first follow-up measurement for each study. The average change in
behaviour from baseline to follow-up across all studies was small and negative (Cohen’s d= –0.03, 95% CI
–0.04 to 0.11). Length of follow-up was a significant moderator in that the change in behaviour from
baseline to follow-up increased as the length of follow-up increased. Behaviour type was also a significant
moderator in that socially desirable behaviours showed a small increase from baseline to follow-up, whereas
socially undesirable behaviours showed a small but significant decrease. Subgroup analyses showed
significant decreases in binge drinking, risky driving, sugar snack consumption and sun-protective behaviour.
The authors conclude that ‘Measurement of intention at baseline resulted in significant decreases in
undesirable behaviours. Changes in undesirable behaviours reported in other studies may be the result
of the mere measurement effect’.53 However, there are several problems with this interpretation.
The included studies measured all the TPB constructs at baseline and so it is difficult to attribute any
mere measurement effect to the measurement of intention specifically. Although the authors argue
that by selecting prospective studies research participant effects other than mere measurement can be
ruled out, it is not clear that this is the case. For example, observed changes in behaviour could result
from social desirability effects. It is also not clear whether the observed changes represent real
changes in behaviour or simply changes in reporting.
The reviews varied in quality. AMSTAR 2 total scores (calculated by assigning 1 point for ‘yes’ and
0.5 points for ‘partial yes’, with a maximum of 16 points) ranged from moderate (i.e. 8.5 points for
Rodrigues et al.9 and 9 points for Wilding et al.11) to low (i.e. 3 points for Spangenberg et al.3 and
3.5 points for Wood et al.10). Although the checklist is not designed to generate a total score,
the score nevertheless gives an overall indication of quality.
McCambridge and Kypri
McCambridge and Kypri8 included eight trials of the effect of answering questions on alcohol drinking
behaviour. Between-group differences were 13.7 (95% CI –0.17 to 27.6) grams of alcohol per week and
1 (95% CI 0.1 to 1.9) point on the Alcohol Use Disorders Identification Test score. Therefore, answering
questions on drinking in brief intervention trials appears to alter subsequent self-reported behaviour.
Discussion
The four recent reviews3,9–11 of the QBE that included studies with a comparison or control condition
yielded similar small, positive effect size estimates, ranging from 0.09 to 0.28 (Cohen’s d). These should
not be considered to be completely independent estimates because of the overlap in included studies.
However, the overlap was less than might be expected. The reviews come to different conclusions
about the practical significance of these findings. For example, Wood et al.10 state that ‘Within the
health domain, a large number of studies have demonstrated that the QBE can be harnessed as an
effective intervention . . .’.10 By contrast, Rodrigues et al.9 suggested that the observed effect size could
overestimate the true effect size and that future studies should compare the QBE with simply sending
reminders to perform the behaviour (see also the commentary by Rodrigues et al.14).
The existing findings for moderators could be used to identify conditions under which a small or zero
QBE could be expected, which would enable investigators to minimise the QBE. However, the findings
for moderating variables are relatively weak. They are based on correlational evidence (i.e. study
characteristics that are associated with larger or smaller effect sizes for the QBE) and the moderators
are frequently correlated with each other. In some cases, the moderators were assessed only indirectly.
For example, Wood et al.10 assessed the potential moderator ‘attitude accessibility’ for each included
study by multiplying an independent rating (by the review team) of attitude for the target behaviour
and sample by the response rate to the questionnaire. The findings are often based on a small
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subset of studies and statistical significance is often close to 0.05. In many cases the results need to
be replicated.
Rapid review of studies of reactivity to objective measurement of behaviour
In research on health behaviours, self-report measures of behaviour are ubiquitous. Such measures
have well-known limitations (e.g. social desirability bias), and it is common to see recommendations
for researchers to use so-called objective measures of behaviour that are assumed to have fewer
limitations. However, objective measures may have their own limitations. For example, objective
measures may have reactive effects on behaviour (e.g. measuring behaviour objectively may lead to
increases in that behaviour).
To identify relevant background literature for the MERIT study this review aimed to identify studies
that have examined the possible reactive effects of objective measurement of behaviour. The review
included the following health-related behaviours: physical activity, diet/food choice, smoking, alcohol
and drug use, dental behaviours and medication adherence.
The following databases were searched, limited to English-language articles published in peer-reviewed
journals between 2008 and 2018 (inclusive): PsycINFO, MEDLINE and PubMed. Searches were limited
to the titles and abstracts of the papers. The reference lists of identified papers were searched
manually for additional relevant papers. Titles and abstracts were screened by one reviewer. Full-text
versions of relevant articles were obtained and screened by the same reviewer.
Fourteen articles13,55–67 on physical activity and two papers68,69 on medication adherence were included
in the review. No studies of smoking, alcohol, drugs, diet or dental behaviours were included.
Evidence of reactivity was found in some physical activity studies but not in others. Based on studies
that used experimental research designs, the following broad conclusion for practice can be made:
l If the aim is to measure physical activity, rather than to increase it, do not ask participants to use an
unsealed pedometer (i.e. a pedometer that discloses step counts to the participant) and to record
their steps. Instead, use either an accelerometer or a sealed pedometer (i.e. a pedometer that does
not disclose step counts to the participant) and exclude data from the first few days of use.
The two studies68,69 of reactivity to objective measurement of medication adherence using electronic
containers suggest that objective measurement may increase adherence but that the effect is
temporary and/or relatively small and so can be ignored, particularly if a run-in period is used
(i.e. a period of monitoring from which adherence data are discarded).
This review shows clearly that more work is needed on the possible reactive effects of objective
measurement. Future work should consider using experimental designs rather than simply longitudinal
studies of objective measurement, the findings from which are difficult to interpret. Experimental
designs can be used to test whether or not there is a ‘main effect’ of objective measurement and to
estimate the size of this effect. They can also be used to isolate key components of measurement that
may account for the reactive effect (e.g. feedback of behavioural information to the participant via a
display of steps on a pedometer as opposed to simply wearing a pedometer with no feedback).
With developments in technology and increasing awareness of the limitations of self-report measures
of behaviour there is likely to be increasing use of objective measurement of behaviours in health
behaviour research.
Existing guidance on measurement reactivity
The aim of the third rapid review was to identify existing guidance statements or recommendations on
how to reduce bias from MR in trials.
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A search was conducted of all CONSORT statements/papers and Medical Research Council (MRC)
framework/guidance on complex interventions (all versions as well as of MRC guidance on process
evaluation in trials. Each document was reviewed for any relevant content related to guidance on
reducing the risk of bias from MR in trials. Furthermore, the full texts of the studies included in the
two rapid reviews discussed in Rapid ‘review of reviews’ of studies of measurement reactivity and Rapid
review of studies of reactivity to objective measurement of behaviour were checked for any reference to
existing guidance on MR. Members of the MERIT study team were also consulted to find out if they
were aware of any existing guidance or recommendations related to MR.
We were not able to identify any existing guidance statements or recommendations on how to reduce
bias from MR in trials from any of these sources. To the best of our knowledge, the present document
is the first to present recommendations on how to reduce bias from MR in trials.
Delphi procedure to inform the scope of the recommendations
The MERIT study included a Delphi procedure70 to explore and, as far as possible, combine the views of
experts to reach agreement on the precise issues that the recommendations will cover (i.e. the scope
of the recommendations). The objectives of the Delphi procedure were to:
1. seek expert opinion from stakeholders on the specific topics where recommendations on MR are
needed and likely to produce the largest benefits
2. identify key background literature and expertise on MR.
Methods
Delphi participants were purposively recruited and identified by examining authorship of relevant
studies as well as using knowledge within the multidisciplinary research team of people with
relevant expertise. The aim was to identify individuals with wide-ranging expertise relating to MR,
trial design, conduct and analysis as well as to identify individuals who are likely to be key users
of the final recommendations, including those involved in research synthesis and funding
(see Acknowledgements).
Participants were asked to complete two rounds of an online questionnaire over a period of
approximately 12 weeks from May 2018. The first round of the Delphi procedure involved 15 open-
ended questions, allowing participants to share their views on what sorts of bias can arise from MR,
the mechanisms by which measurement produces changes in people, and the characteristics of study
design, interventions, measurement and context that can lead to such biases. Suggestions were also
sought on key literature on MR.
Responses from round 1 of the Delphi were developed into themes that were then used to inform
the round 2 questions. Participants from round 1 of the Delphi were asked to complete round 2. The
second round of the Delphi presented participants with a list of specific topics that recommendations
might consider. Participants were asked to rate their agreement with these suggested topics as well as
to provide open-ended comments if they thought that any key issues were missing.
Results
A total of 40 participants took part in round 1 of the Delphi procedure (119 invitations were sent in
total), covering a wide range of expertise, as shown in Table 2. Among these, 31 (78%) participants
took part in the second round. The findings of the Delphi procedure were then provided to delegates
at an expert workshop (see Expert workshop to develop content of the recommendations).
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The results of round 2 of the Delphi process are shown in Table 3. Each specific topic for inclusion
was categorised into a subgroup topic (see Table 3, last column). These subgroup topics formed major
components of the agenda at the expert workshop held in October 2018. Participants were provided
with the ratings in Table 3 to help inform discussion.
Expert workshop to develop content of the recommendations
An expert workshop was held in Manchester on 4 and 5 October 2018. A total of 23 delegates
attended the workshop. The delegates covered a broad range of expertise similar to that covered
by the Delphi procedure (see Acknowledgements). Delegates were provided with reports of the
evidence reviews (see Asking questions changes health-related behaviour: an updated systematic review
and meta-analysis of randomised controlled trials, Rapid ‘review of reviews’ of studies of measurement
reactivity, Rapid review of studies of reactivity to objective measurement of behaviour and Existing guidance
on measurement reactivity) and the results of the Delphi procedure (see Delphi procedure to inform the
scope of the recommendations) and were encouraged to refer to these as a basis for further discussions.
The content of appropriate recommendations was discussed by the workshop delegates and these
statements form the central part of the current recommendations. As informed by the Delphi procedure,
discussions were conducted in subgroup and plenary sessions and structured around study design and
bias, measurement procedures, appraisal of existing trials, trial conduct and statistical analysis.
The MERIT study team have written the current report based on notes of the workshop discussions.
All workshop delegates were given opportunity to review and comment on the report and
recommendations before it was finalised.
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TABLE 3 Results of Delphi round 2 (n = 31)
Topic
Response, % (n) [points]
Response
















Strategies for carefully designing trials to reduce
the risk of bias due to MR
0 (0) [0] 3.23 (1) [2] 3.23 (1) [3] 38.71 (12) (48] 54.84 (17) [85] 31 138 4.45 Study design
How to predict when MR could lead to bias
in a trial
0 (0) [0] 0 (0) [0] 9.68 (3) [9] 38.71 (12) [48] 51.61 (16) [80] 31 137 4.42 Bias/appraisal
Approaches to ensure measurement/assessments
are not confounded with the intervention
0 (0) [0] 3.33 (1) [2] 13.33 (4) [12] 40 (12) [48] 43.33 (13) [65] 30 127 4.23 Study design
How to anticipate when MR is likely to be
present in a trial
0 (0) [0] 0 (0) [0] 12.9 (4) [12] 58.06 (18) [72] 29.03 (9) [45] 31 129 4.16 Study design/
appraisal
How to identify risk of bias due to MR in
existing trials
0 (0) [0] 3.23 (1) [2] 6.45 (2) [6] 61.29 (19) [76] 29.03 (9) [45] 31 129 4.16 Appraisal
How to interpret trials that are at risk of bias
due to MR
0 (0) [0] 0 (0) [0] 16.13 (5) [15] 51.61 (16) [64] 32.26 (10) [50] 31 129 4.16 Appraisal
How to identify the types of bias arising from MR 0 (0) [0] 0 (0) [0] 23.33 (7) [21] 50 (15) [60] 26.67 (8) [40] 30 121 4.03 Bias
Considerations in selecting measurement tools
(e.g. objective vs. subjective) to reduce the risk of
bias due to MR
0 (0) [0] 6.45 (2) [4] 22.58 (7) [21] 38.71 (12) [48] 32.26 (10) [50] 31 123 3.97 Measures
Recommendations on how unobtrusive methods
of data collection could be used to remove or
reduce the risk of bias due to MR
0 (0) [0] 9.68 (3) [6] 16.13 (5) [15] 41.94 (13) [52] 32.26 (10) [50] 31 123 3.97 Measures
Considerations in planning the timing and number
of repeated measurements to reduce the risk
of MR
0 (0) [0] 3.23 (1) [2] 25.81 (8) [24] 45.16 (14) [56] 25.81 (8) [40] 31 122 3.94 Study design
Provision of hypothetical/existing study examples
to illustrate principles behind guidelines
0 (0) [0] 3.23 (1) [2] 29.03 (9) [27] 41.94 (13) [52] 25.81 (8) [40] 31 121 3.9 All
Strategies for statistical analyses of trial outcome
data that aim to estimate, and adjust for, the risk
of bias due to MR
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Strategies to improve use of self-report measures
to reduce the risk of MR
0 (0) [0] 6.45 (2) [4] 29.03 (9) [27] 35.48 (11) [44] 29.03 (9) [45] 31 120 3.87 Measures/
trial conduct
Considerations in undertaking pilot studies to
identify potential measurement reactions and
how they may be addressed
0 (0) [0] 9.68 (3) [6] 22.58 (7) [21] 48.39 (15) [60] 19.35 (6) [30] 31 117 3.77 Study design
How to conceal measurements from participants
or limit feedback as a way to reduce the risk
of MR
0 (0) [0] 19.35 (6) [12] 16.13 (5) [15] 32.26 (10) [40] 32.26 (10) [50] 31 117 3.77 Measures/
trial conduct
Recommendations on how the research team
should interact with research participants to
reduce the risk of MR
0 (0) [0] 3.33 (1) [2] 30 (9) [27] 53.33 (16) [64] 13.33 (4) [20] 30 113 3.77 Trial conduct
Strategies for handling risk of bias when a study’s
aims require different measurement procedures
across arms of a trial
0 (0) [0] 6.45 (2) [4] 35.48 (11) [33] 35.48 (11) [44] 22.58 (7) [35] 31 116 3.74 Analysis
The circumstances in which one might use non-
standard trial designs (e.g. Solomon four-group
designs) to assess extent of bias and/or yield
unbiased estimates of effects
0 (0) [0] 6.45 (2) [4] 38.71 (12) [36] 32.26 (10) [40] 22.58 (7) [35] 31 115 3.71 Study design
Identification of gaps in knowledge on MR and
how to minimise risk of bias in trials due to MR
0 (0) [0] 19.35 (6) [12] 19.35 (6) [18] 35.48 (11) [44] 25.81 (8) [40] 31 114 3.68 All
Identification of research priorities for better
understanding of MR and potential for bias
3.23 (1) [1] 16.13 (5) [10] 19.35 (6) [18] 35.48 (11) [44] 25.81 (8) [40] 31 113 3.65 All
Which fields of research are most affected by
bias due to MR
0 (0) [0] 12.9 (4) [8] 29.03 (9) [27] 45.16 (14) [56] 12.9 (4) [20] 31 111 3.58 Bias/appraisal
How to assess extent of MR during an internal
pilot phase of a trial
0 (0) [0] 16.13 (5) [10] 25.81 (8) [24] 41.94 (13) [52] 16.13 (5) [25] 31 111 3.58 Analysis/
trial conduct
Ethical implications of strategies to address MR 6.45 (2) [2] 16.13 (5) [10] 25.81 (8) [24] 32.26 (10) [40] 19.35 (6) [30] 31 106 3.42 All
How biases caused by MR might relate to existing
risk-of-bias frameworks

























































































































































































































































































TABLE 3 Results of Delphi round 2 (n = 31) (continued )
Topic
Response, % (n) [points]
Response
















Theoretical explanations that may plausibly
explain the effects of measurement on people
who have been measured (mechanisms)
3.23 (1) [1] 22.58 (7) [14] 32.26 (10) [30] 29.03 (9) [36] 12.9 (4) [20] 31 101 3.26 Mechanisms
Recommendations on selection of research
participants (recruitment strategies and inclusion
criteria) to reduce the risk of MR
6.45 (2) [2] 32.26 (10) [20] 32.26 (10) [30] 16.13 (5) [20] 12.9 (4) [20] 31 92 2.97 Trial conduct
How research participants may make use of
measurement for their own purposes (which may
lead to bias)
0 (0) [0] 43.33 (13) [26] 30 (9) [27] 16.67 (5) [20] 10 (3) [15] 30 88 2.93 Trial conduct
Total number of respondents (for this survey round) 31
Total number of responses 832
Point average (total points all rows/responses for all rows) 3.79


































































A notable limitation of the MERIT study was the shortage of high-quality evidence regarding the extent
of MR (with some notable exceptions) and the circumstances that are likely to bring it about. There is a
particular lack of direct evidence regarding the extent to which MR produces bias in trials. Accordingly,
development of the final recommendations has relied extensively on indirect evidence processed by
expert opinion, which is contingent on reasonable inference regarding the likely consequences of
measurement in producing bias.
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The present chapter makes a series of recommendations for people designing and conducting trials.
In developing these recommendations, a limitation is the current state of knowledge. There is some
evidence regarding the circumstances under which measurement will lead to reactivity, but little direct
evidence about the extent to which it causes bias, let alone the effectiveness of any steps that could be
taken to reduce bias.2 Given this, many of these statements are broad recommendations about issues
that may be useful to consider on the basis of indirect evidence processed by expert opinion.
The recommendations are grouped into three broad types of recommendations: (1) identify whether or
not MR is likely to be a major source of bias for a new trial, (2) collect further data to inform decisions
about whether or not there is risk of bias resulting from MR and (3) potential actions to minimise risk
of bias from MR within a trial.
Identify whether or not measurement reactivity is likely to be a major
source of bias for a new trial
It is worth noting that, in some cases, the risk of bias from MR in a particular trial may be so small that
it can safely be ignored. Consideration of the ways in which MR may lead to bias, as well as other
potential sources of bias, and how bias can be prevented lies at the heart of rigorous approaches to
trial design and conduct. No triallist can discount selection bias or other forms of bias without properly
accounting for the risk in the specific circumstances of their trial.25 In many circumstances, although
bias from MR may be present, it is likely to be of small magnitude compared with other sources of bias,
such as failure of randomisation.9 It may also be impossible to isolate bias from MR if there are other
sources of bias. The features listed in Table 4 suggest circumstances in which MR bias may be more
important. It is, however, worth considering that reactions to assessment can exacerbate or contribute
to other sources of bias that have previously received more attention.7 As discussed in Chapter 2,
reactions to measurement can be implicated in several well-known forms of bias.
Recommendation 1: consider potential for measurement reactivity causing bias at the
design stage of a trial
It will be easier to prevent MR causing bias than it will be to deal with the consequences of bias
through analysis after the event. Therefore, researchers should consider at the outset whether or
not the trial they are planning is likely to produce this bias. It is important to consider the many
measurement and assessment processes involved in a trial. This may include assessment of eligibility,
baseline assessments, assessments of adherence or fidelity, process evaluations (quantitative and
qualitative) and interim/final outcome assessments. Each of these measurement or assessment
processes has the potential for causing MR and thereby introduces the potential for bias.
It is also important to be clear when measurement is an integral part of the intervention and, hence,
should not be considered a source of bias per se, although there may be contamination issues to
consider carefully. In many studies ongoing measurement may be part of an intervention (i.e. it would
be part of the intervention were it to be rolled out in practice outside a trial). For instance, many
weight management programmes may include regular measurement of body weight as an integral
part of the intervention.71 In this case, although regular weighing would be carried out only in the
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TABLE 4 Trial features that may indicate risk of bias due to MRa
Criterion indicating risk of bias Circumstances under which risk of bias is likely to be higher
Participant selection
Recruitment Selection on personal motivation for participation in the trial
Eligibility criteria Restrictive eligibility criteria
Education More educated (e.g. university students)
Measurements
Features of health outcome of interest
Participant awareness of health-related outcome
of interest
Participants aware of outcome of interest (open)
Nature of health-related outcomes Outcomes focused on behaviour or anxiety; health-promoting
behaviours (e.g. physical activity)
Social desirability of health outcome Outcomes with well-recognised social norms
(e.g. body weight)
Follow-up
Number of measurement occasions Measurements repeated on several occasions
Length of time to follow up Short in relation to possible measurement effects
Features of measurement procedures/tools
Equivalence of measurement procedures across
trial arms
Differential across trial arms
Similarity between measurement and BCTs Measurement directly mimics BCTs
Source of data New data collected specifically for this study
Measurements open to subjectivity Self-report measures
Disclosure of measured values to participants Values disclosed to participants (immediately)
Burden of measurement task Onerous for participant
Complexity of measurement task Complex for participant
Measurement framed in terms of goals/targets Participants measured against specific goals/targets
Context Laboratory setting
Interventions and comparators
Nature of the intervention Behavioural and/or self-monitoring components included
Blinding to arm allocation Lack of blinding to arm allocation
Process evaluation
Process measures Measures included are assessing mechanisms of action on the
primary outcome
Timing Conducted before/during trial outcome assessments
Trial arms included Conducted in only one trial arm
Number of data collected Extensive data collected from all participants
BCT, behaviour change technique.
a Please refer to explanatory text for each entry in Appendix 5. When available, supporting evidence is cited
in the appendix.
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intervention group and not in the control group, any reactions to this measurement would not
constitute bias (i.e. the reactions are due to an integral part of the intervention). By contrast, if such
regular weighing were not part of the programme were it to be rolled out, then the assessments would
be a feature of the trial design rather than the intervention design, and this imbalance between
experimental arms has the potential to produce bias. For these reasons, it makes sense to have a single
clear purpose for each measurement.
Recommendation 2: consider potential for measurement reactivity as a source of bias
throughout the research process
As one moves from early trial planning through detailed study design to giving attention to issues
arising from study conduct, it is important to consider all instances of measurement that can occur
throughout the research process. For instance, when assessing eligibility of a potential participant for a
trial, disclosure of health status (e.g. blood pressure or cholesterol level) to research participants at the
beginning of a clinical trial could potentially lead to measurement reactions. For example, in a trial
evaluating the effect of a behavioural intervention compared with usual care, disclosure of health
status to participants could motivate the comparison group to seek additional support. Participants’
knowledge of their health status could also make them more or less receptive to an intervention.72
This might be particularly problematic when subgroups of the population with a particular health risk
are recruited to take part in a trial (e.g. people with obesity or people who drink alcohol heavily).8 It is
not difficult to imagine how, by simply engaging in the measurements required to assess eligibility into
the trial, participants become aware of their health status and might change their thoughts, emotions
or behaviour as a result. In such instances, there is a need to be careful around communications with
participants regarding how measurements are used.
At the consent stage participants are often informed of the trial objectives through the patient
information sheet as well as through possible informal interactions with trial personnel. Participants
may then perceive specific behavioural trial outcomes to be implied norms or goals in the context of
the research. This may predispose to MR, which may introduce bias subsequent to randomisation.4
Patient information sheets should be carefully drafted so as to emphasise the concept of equipoise and
the equal value attached to alternative trial interventions and outcomes. Patients may be asked to
consent to masking of measurements and non-disclosure of measurement values (see Recommendation
13: consider the potential benefits of masking measures and/or withholding feedback of measured values
against ethical considerations). Trial personnel should follow standard operating procedures (SOPs) that
regulate informal communications with participants at the recruitment/consent stage.
In some trials, for example cluster RCTs73 and others based on routine health records,32,33 consent
may not always be required at the individual participant level. Consent at general practice level, for
example, enables trials to be conducted with lower levels of awareness among patients of research
participation. Gaining consent at a group level in this way can help to avoid participants’ awareness
of the health outcome of interest for the trial and the potential for MR to take place based on this
knowledge. However, MR alone is unlikely to be a main justification for choice of a cluster
randomised design.
Baseline measurements in a trial typically contribute to efficient design by enabling more precise
estimation of the intervention effect.74 However, when trial participants are exposed to baseline
measurements this may contribute to MR and heighten risk of bias. This is because experiences of a
previous measurement within a trial may influence responses at later measurement occasions and/or
interact with the study intervention. These testing effects may differ according to subsequent trial
arm allocation.
It is generally recognised that recording the delivery of face-to-face interventions results in greater
adherence to intervention protocols, which can be problematic when fidelity assessments are taking
place.75 This is probably unproblematic in efficacy or ‘proof of principle’ studies, in which high levels
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of adherence allow easier interpretation of whether or not an intervention delivered as intended
demonstrates efficacy.76 However, in effectiveness studies, in which one is aiming to examine the
effects of an intervention delivered in more ‘real-world’ settings and in which such fidelity assessments
would not be enacted in routine implementation, any reactions to these assessments form an example
of MR, as discussed in the present document. When the fidelity assessments are enacted in routine
implementation (e.g. as part of quality assurance processes), they can be considered to be part of an
intervention and, hence, any reactions to these assessments are not problematic. Assuming that
adherence to the intervention protocols is not part of future practice (assuming the intervention is
successful) and is likely to result in greater effects, then the use of fidelity assessments is likely to
result in bias through overestimation of intervention effects (see Chapter 2).
It is good practice to draw up SOPs for the measurement procedures that encompass issues noted
in this report, including consistency of measurement procedures across trial arms, masking and
non-disclosure of measurement values, number of measurement occasions, etc. The SOPs should
extend to regulating informal contacts/communications between trial participants and health-care
providers or trial personnel either at the time measurements are taken or on other occasions.
The prospect of future measurement may also produce changes in research participants. For example,
anticipatation of measurement of body weight can lead to changes in feelings of self-efficacy and
self-control, as well as increased accountability for one’s own actions,77 which could potentially affect
adherence to physical activity and healthy eating guidance, particularly shortly before such measurements.
Similarly, electronic monitoring of medication adherence can lead to changes in adherence.69 That is,
knowledge or anticipation of measurement or disclosure of outcomes, as well as actual measurements
conducted, should be considered as potential sources of reactivity.
Recommendation 3: consider specific trial features that may indicate heightened risk of
bias due to measurement reactivity
Table 4 provides a series of ‘red flags’ or trial features that might indicate that MR should be
considered a possible risk of bias in a study. Based on the consensus views of experts consulted for
this report, it highlights features of study participants, types of interventions, features of study design
and measurement issues where MR may be more likely to occur and lead to bias. Table 4 should be
consulted alongside the explanatory text in Appendix 5. When direct evidence is available to support
entries in the table, then this is cited in Appendix 5; otherwise, the entries are based on consensus
views of experts consulted as part of the MERIT study (see Chapter 3 for a description of the process
used to develop recommendations).
The entries in Table 4, or ‘red flag’ features of study design, indicate only potential for bias from MR,
which may be absent on closer examination or identified as a possibility and mitigated through careful
study design. The potential for measurement as a co-intervention leading to bias is implicit but not
widely articulated in existing tools intended to assist in study design.78 Table 4 provides a checklist
to identify such concerns. Researchers should refer to Table 4, and associated text in Appendix 5, to
determine whether or not MR and risk of bias arising from this is likely to be particularly relevant to
their particular study and, if so, should further consider the following recommendations about reducing
the potential for bias. Some key issues contained in Table 4 are illustrated in worked examples
contained in Boxes 3 and 4.
Recommendation 4: theorise potential measurement reactions as part of a logic model of
how an intervention is intended to work
It is now recognised that developing a programme theory for how an intervention might have an
intended effect on a primary outcome or constructing a logic model that specifies the pathways by
which an intervention results in the intended outcomes is good practice and can help in selecting
appropriate measures and making theory explicit in a trial.79–81 It has also been proposed that it is
useful to develop models of ‘dark logic’ by which interventions may produce harmful effects that are
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BOX 3 Assessing likelihood of bias due to MR: a worked example
We describe below a hypothetical trial in which there is a high likelihood of bias due to MR to illustrate the
issues highlighted in Table 4. Please note that this example includes several features of poor trial design.
This is deliberate to illustrate issues that are explicitly related to ‘red flags’ in Table 4.
A trial is designed to assess the effectiveness of an intervention to promote maintenance of weight loss
in people with type 2 diabetes who have lost 5 kg, relative to usual care. The intervention is designed to
be delivered entirely online and involves self-monitoring of body weight, physical activity and dietary
behaviours as well as encouragement to seek social support for maintenance of weight loss. To assess the
intervention’s mechanism of effect, 25% of participants in the intervention group are required to engage
in a process evaluation. This involves patients attending their general practices to be weighed. These
participants are also asked to complete questionnaires about their dietary and physical activity behaviours
online. A different subsample is asked to participate in focus groups to discuss how useful they found the
online intervention.
This trial has numerous features that suggest it is likely to produce a biased outcome due to MR. First,
the intervention is a fairly minimal contact digital intervention and so any effect of this intervention on
body weight is likely to be small. Therefore, the effects of MR do not have to be large to have a relatively
substantial effect. Second, all participants are likely to be motivated to achieve the outcome, given that
they have already lost 5 kg in body weight, and so they are likely to be very interested in the results of
measurements made. Third, there is unbalanced measurement, with those in the intervention group
receiving substantially more process measurement (i.e. attendance at general practices involves a quite
burdensome form of measurement). Fourth, the process evaluation mimics some of the intended effects
of the intervention because it involves (1) regular weighing, (2) regular reflection on behaviour through
completion of questionnaires and (3) contact with other people who could provide social support. Fifth,
because the study is not blinded, the staff at the general practices will be aware that the intervention
participants are trying to maintain weight loss and may offer encouragement or other advice. The mere
fact that body weight will be monitored by others may promote attempts to maintain weight loss.
Last, the outcomes of measurement are likely to be available to intervention participants and so
they may be receiving more information than participants in the other experimental condition.
BOX 4 A worked example of actions to take when there is suspicion of MR being a major source of bias
This box considers what actions could reasonably be taken to address the high likelihood of risk of bias of
the hypothetical trial described in Box 3. Please note that, even in the absence of the onerous process
evaluation, the evaluation of this particular intervention in a trial invokes the risk of measurement reactions
introducing bias because measurement is intrinsic to both intervention and trial design. The selection criteria
create risks to be considered because they seek participants who have already demonstrated that they are
motivated volunteers and they may have varying strengths of preferences for allocation. Communications
with trial participants from the information sheet onwards need to be carefully constructed throughout the
study to provide assurance about the equal value attached to both trial arms.
The process evaluation makes measurement differential between arms and so a strong justification is required,
which makes the risks of bias worth considering in relation to other considerations. To inform this process
of decision-making it would be helpful to elaborate a programme theory of how this intervention seeks to
produce the weight loss maintenance outcome. This could be useful because it will clarify thinking about how
measurement and other features of study design may operate in relation to the possible mechanisms of effect.
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Some amendments to the study design or conduct may appear warranted when using the programme
theory. For example, this may identify that the hypothesised mechanism of action for the intervention is
similar to the unwanted effects of the process evaluation. This might lead the researchers to consider
reducing the amount of measurement in the intervention arm, using similar measures with the control
group or, perhaps better still, minimising the effects of the process evaluation. For example, the timing of
focus groups should be delayed until after the primary outcome is assessed. The researchers may also
decide to train administrative, clinical and research personnel in how best to interact with trial participants
(e.g. regarding communication of weight measurements or the parameters of informal chat). There could be
a trade-off in making the measurement experience as positive as possible to aid trial retention, with the
risks that it may orientate participants to weight loss issues in ways that affect key behaviours. In many
situations it will be acceptable to tolerate measurement reactions if retention is optimised, although in
such circumstances capturing the extent of measurement reactions to assess their equivalence will often
be worthwhile.
In this trial the participants are very likely to have been engaged with the weight management issues that
are being measured for many years. Appreciation of how the participants regard the trial eligibility and
subsequent measurement procedures is likely to be valuable. For example, some participants might be
expected to use the annual measurement points as providing deadlines or targets in ongoing struggles with
their own body weight. Indeed, in this study it is clear to all which outcomes are being studied. Therefore,
designing a study to try to avoid participants using measurements for their own purposes may not be
appropriate. Instead, it may be more appropriate to seek to study this phenomenon. If participants in both
arms use the measurements in similar ways then bias is unlikely. For these reasons, the research team might
undertake one of a range of feasibility studies before the trial. The team could interview participants after
administering the planned baseline and/or process measurement procedures with a view to identifying
content that is particularly salient to ongoing weight management. If this is done for both control and
intervention arms that differ in terms of extent of measurement, it will provide data on possible differences
between arms due to unbalanced measurement. These findings should then inform decisions about the
content, timing and procedures for the main trial.
If the feasibility work suggests important reasons to be concerned about reactive effects of measurement,
the research team should consider SWATs. Again, there is a wide range of possibilities to consider.
These could include randomised comparisons of the volume and contents of measurement, with the
former testing the effect of reducing measurement overall. Similarly, they could be directed towards
study organisational issues or research staff conduct (e.g. comparing the effects of training vs. no training
on participant interactions). Such studies would need to be designed without prejudice to evaluation of
the main trial outcome and the statistical power to detect any possible effects considered. The same is true
of the process evaluation. The team might decide to randomise a lower proportion of participants to the
evaluation and make an a priori decision for main trial analysis to take account of the effect of process
evaluation. SWATs do not need to be randomised. Qualitative studies of research staff accounts of their
interactions with participants could be undertaken for both trial arms and contribute data to the statistical
analyses. Such data could also be useful in integrating the trial outcomes with findings of the process
evaluation, as is recommended in existing MRC guidance.79
SWAT, study within a trial.
BOX 4 A worked example of actions to take when there is suspicion of MR being a major source of bias (continued)
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not intended to better understand such phenomena.82 In line with this, it may be helpful to consider
the pathways by which measurement at any stage of the trial may produce bias.
Researchers may want to consider how participants may react to the processes of measurement and to
what extent the scenarios presented in Chapter 2 may be applicable to their trial.
Researchers may also find it helpful to consider how the measurement process might interact with the
intervention (e.g. as a source of information or by prompting participants’ greater reflection than they
would otherwise engage in).83 It may be particularly useful to consider how changes brought about by
measurement may interact with responses to the intended intervention. To construct such logic models
it may be useful to involve members of the public or relevant patient groups, as well as to draw on the
knowledge of the research team of the phenomenon under investigation.
The existing literature summarised in Chapter 3 is helpful to consider with regard to the potential for
MR, but it is by no means exhaustive. In considering whether or not bias from MR is likely to be of
concern for a specific trial it may be helpful to refer to this evidence base and other relevant published
literature to ascertain if there is evidence that the measurement tools and procedures you plan to use
are likely to change research participants’ thoughts, emotions or behaviour. Recommendations on
decision-making on conducting further empirical work to explore MR are presented later (see
Recommendation 7: consider whether or not measurement reactivity concerns for your trial warrant further
empirical examination).
Recommendation 5: consider the burden of measurement procedures and potential impact
on participants in comparison with the intensity and duration of the studied intervention
Regular contact with research personnel for measurements might help sustain participants’
engagement and therefore continuation in a trial, thus providing one rationale for the use of interim
measurements. Alternatively, some trials have measurement points only at baseline and at a single end
point, perhaps because researchers recognise that measurement may produce effects that are large
compared with a comparatively minimal intervention.84 It may be preferable to use non-measurement-
related activities (e.g. newsletters) to support participants’ engagement in a trial. It is particularly
concerning when the amount of contact or interaction with researchers or clinicians for baseline and
follow-up measures is greater than the amount of contact or interaction with the intervention (e.g. in
very brief interventions).85 Feedback from researchers conducting measurements with participants may
suggest that MR could be an issue in such circumstances (see Recommendation 8: examine feedback from
research personnel regarding research participants’ reports of changes in their behaviour/thoughts/emotions as
a result of measurement).
Recommendation 6: consider how participants may use measurement in trials to meet
their own aims
It may be helpful to take a participant-centred approach to theorising around research participants’
potential for measurement reactions.7 Much research examining the effects of measurement conceptualises
the process of measurement as affecting passive participants. By contrast, it may be helpful to consider
participants as actively pursuing their personal goals when considering the possible effects of MR in
producing bias.86 This means paying careful attention to how participants or prospective participants
engage with the features of trial design. For instance, people may wish to take part in a trial to promote
physical activity to gain access to outcome measurements (e.g. blood pressure or weight) or to receive
regular feedback on their activity levels from an accelerometer. These outcome measurements may be
intrinsically motivating in their own right and can produce changes in physical activity irrespective of the
intended effects of the intervention.
Other possible goals of participants may produce patterns of responding to measurements. For instance,
participants who are being assessed by health-care professionals with whom they have regular contact
may wish to respond in such a way as to create a particular impression of need (i.e. to elicit services) or
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competence (i.e. if they wish to create a productive relationship). Therefore, regular measurement may
produce changes in self-reported outcomes. In the absence of blinding, if participants believe that the
treatment should be more widely available, they may exaggerate the personal benefits of a treatment to
provide evidence of a positive effect of the intervention.
Arguably, the more extensive or meaningful the measurement is to a participant in a trial, the more
it becomes possible that the participant will react in ways that have not been foreseen by the
researchers. For example, the effects of participants using measurements in trials to meet their own
aims are likely to be larger when the measurements are particularly important (e.g. when involving
additional checks for people with diabetes or regular monitoring for relapse in people who have had
cancer). Similarly, when highly valued concerns (e.g. the adequacy of one’s own parenting) are asked
about, it may be that this process leads participants to reflect on their behaviour in ways that may lead
to change. Likewise, if painful experiences are explored, it would be unsurprising if this was not to have
an impact in some way, which may have implications for data collected subsequently in the study.
Collect further data to inform decisions about whether or not there is risk
of bias resulting from measurement reactivity
Given the current state of knowledge, researchers will sometimes have reason to be concerned that
MR will be a problem for their trial. However, they may find there to be insufficient knowledge about
the extent to which it is likely to be present or if it could lead to risk of bias. This situation creates
dilemmas. In these cases it may be sensible to collect further quantitative or qualitative information to
inform decisions about potential modifications to trial design that aim to reduce the risk of bias from
MR (see Potential actions to minimise risk of bias from measurement reactivity within a trial).
Recommendation 7: consider whether or not measurement reactivity concerns for your
trial warrant further empirical examination
Having gone through processes indicated in recommendations 1–6, a judgement is required about the
likelihood of risk of bias resulting from MR for a particular trial and whether or not any additional
action is then needed. Options vary from taking no further action and proceeding with the trial as
planned (when likelihood of risk of bias is very low) to conducting the trial using a Solomon four-group
design87 (described below) when likelihood of risk of bias is very high. These two options represent the
ends of a spectrum of possible decisions. Figure 3 shows a flow chart to support decision-making, with
options including:
l no further action
l modifying study design using recommendations in Potential actions to minimise risk of bias from
measurement reactivity within a trial
l investigating risk of MR in pilot or feasibility work to inform a main trial
l investigating risk of MR in a study within a trial (SWAT)88
l modifying study design to a Solomon four-group design.
In making these decisions one will have to consider several issues, including the research question(s) for the
study, recruitment and retention of trial participants, other potential sources of bias, resources available
and ethical considerations. The extent of action to minimise bias from MR needs to be proportionate and
weighed against these other concerns. In some cases, relatively simple changes to the study design might
be achievable without unduly negative consequences. For example, pragmatic solutions could be sought to
ensure that measurement procedures are identical across both arms of a trial (e.g. measurements for both
arms conducted by research nurses in a clinic) or references to behavioural goals could be removed from a
questionnaire (e.g. removal of references to ‘five a day’ from a question about fruit and vegetable intake).
However, it is recognised that in some cases other priorities and concerns might outweigh concerns about
potential for bias from MR.
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Follow guidance statements (see Potential actions to minimise risk of bias from 
measurement reactivity within a trial) to minimise risk of MR bias
Weigh up concerns regarding MR against trial design features that are critical 
to address the research question(s), recruitment and retention of participants, 





















Consider SWATs and/or pilot work to test whether or not red flag features lead to
MR in your specific trial context
FIGURE 3 Flow chart to support decision-making for recommendation 7. Boxes in purple indicate potential actions to take following decision-making. Boxes in green indicate issues to
consider in decision-making. Arrows in pink indicate hypothetical interim actions to reach decisions about actions to be taken. Reproduced with permission from French et al.27 This is
an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build
upon this work, for commercial use, provided the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The figure includes minor additions and formatting
























































































































































































































































































In some situations, for example when theorising about MR suggests that bias could be a risk and when
no empirical evidence on reactivity to a particular measurement tool or procedure is available, it might
be appropriate to investigate likelihood of MR in pilot/feasibility studies. Such work would offer the
potential to test reactions to measurement and inform researchers about the extent to which MR
could bias trial findings. Feasibility studies could also be used to determine the presence of potential
measurement reactions and quantify their duration to evaluate whether measurement reactions are
short or long in relation to length of trial follow-up. It is likely that qualitative studies would be
informative in terms of understanding how people could potentially react to measurement and the
way in which measurement procedures might influence decisions to take part in research.
A further possibility is the incorporation of nested methodological studies (SWATs) to estimate the
magnitude of bias from MR in a subset of participants. The use of subsamples comprising participants
who differ in the amount of measurement they receive has the potential to increase understanding of
the effects of measurement. The use of SWATs can contribute to estimations of the likely effect size
of various amounts of measurement when such measurement is randomly counterbalanced between
experimental conditions. Studies that are designed to allow the amount or nature of measurement to
differ can often be inexpensive to carry out and would be scientifically valuable given the current state
of knowledge regarding MR. The size of a SWAT is necessarily constrained by the size of the host trial
and imprecise results may be obtained. A SWAT can nevertheless contribute to the overall body of
evidence through updated meta-analyses.
There are obvious precedents for the use of subsamples undergoing different research procedures. It is
often the case that subsets of participants undergo interviews as part of a process analysis, have their
intervention sessions recorded as part of fidelity assessments or complete additional (often objective)
measures to validate other (often self-report) measures.79 These situations all present potential for bias
due to MR as well as for investigating the effects of measurement on participants through SWATs. In
such situations, there are ways of statistically controlling for these subsamples in analyses, should this
be necessary, as well as making the comparison of these subsamples a focus of investigation in SWATs
in their own right.
The Solomon four-group design aims to provide a method for specifically assessing one aspect of MR:
the impact of baseline (pre-test) measurements on trial outcomes.87 The Solomon four-group design is
a factorial design in which participants are randomised to intervention and control trial arms as well as
to baseline assessment or no baseline assessment. Analysis of this design includes estimation of the
effect of baseline assessment and whether or not this effect differs by trial arm status. Challenges that
limit use of this design include the logistical difficulty of including four trial arms, the likely increased
costs associated with greater sample size requirements and the greater complexity of analytical
approach.23 With these difficulties in mind, it is likely that a Solomon four-group design is warranted
only in trials in which several indicators suggest that MR is a major concern and likely to bias effect
estimation. An alternative approach that may be worth considering is to undertake a large simple trial
that eschews baseline measurement altogether, thereby relying on randomisation of large numbers to
generate equivalence between arms to safeguard the experimental design.89 This may be feasible in
some circumstances.
Recommendation 8: examine feedback from research personnel regarding research participants’
reports of changes in their behaviour/thoughts/emotions as a result of measurement
During the course of a trial, research personnel often have several points of contact with research
participants that involve informal conversations. It is possible that research participants might voluntarily
offer information about changes in their behaviour, thoughts or attitudes that have arisen because
of their participation in the trial or even specifically due to measurement procedures. For example,
participants in a control arm of an alcohol treatment trial might describe how they have tried to cut
down on their alcohol consumption because they did not realise that they were consuming more than
recommended levels until they completed the study questionnaire.
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It is important to allow the reporting of such feedback from research participants volunteering it
(and explicitly asking for such feedback can often be useful) so that common themes can be identified
and acted on if necessary. Dedicated provision for the gathering of such material in data collection
plans may be needed. If research personnel consistently provide feedback consistent with MR, then
such feedback may be able to inform further process evaluations, statistical analysis strategies and/or
interpretation of study findings.
Potential actions to minimise risk of bias from measurement reactivity
within a trial
A number of options are available when consideration of the issues suggests that MR is likely to cause
bias within a trial. These are described below, along with issues that may promote or reduce enthusiasm
for their adoption.
Recommendation 9: consider possible measurement reactivity when determining the
overall burden of measurement in a trial
There is a wealth of evidence that many patient-reported outcomes are collected during research
but often not analysed or reported.90 This has many downsides, including being an unethical use of
participant time (especially when they are in poor health), respondent fatigue and lower response rates
leading to poorer-quality data. For these reasons, generally speaking, less measurement in trials would
be better. In addition, when there are potential problems with measurement having reactive effects,
then having less measurement may reduce the likelihood of bias due to these reactive effects.
There are also compelling reasons for having study measurements. Having baseline measures of primary
outcomes reduces the required sample size through increased power if there is high correlation between
the outcome at baseline and end point, and it allows for statistical adjustments to be made (e.g. when
randomisation has not resulted in similar experimental groups).91,92 Similarly, a primary outcome measure
is required to detect the effects of the intervention at the main follow-up point. It is often desirable for
this primary outcome to be completed on several occasions to allow it to be determined if there were
initial changes in the primary outcome that were not maintained, or if the effects continued to increase
because of changes producing synergistic effects in the longer term.
There are also good arguments for including measures of process to understand how and when
effects are produced. Researchers may wish to consider when it is appropriate for all participants to
complete all measures and how measurement design can be as economical as possible. For example,
an intervention may aim to increase medication adherence by persuading patients that their medication
is necessary for their good health. In this case, one would expect a larger effect on beliefs about the
medication being necessary than on medication adherence because adherence is further down the
causal chain of how the intervention is expected to work. Asking all research participants to complete
these process measures (of beliefs about medication necessity) will almost certainly be unnecessary if
the hypothesised mechanism of action is correct, as the effect size will be considerably larger than will
be the case for the main outcome measure. It should instead be reasonable to ask only a subset of
participants to complete these process measures. Following the same reasoning, it may also be efficient
to investigate two or more hypothesised causal pathways with randomly drawn, or targeted, subsamples
of participants in a single trial with the same primary outcome measure.
The use of process or interim measures within a trial may be particularly problematic for MR. First,
they may act as prompts to enacting the intervention or the behaviour under investigation, particularly
when the intervention is minimal and the measurements are effortful (e.g. wearing a pedometer or
necessitating a visit to see a health-care professional). Second, process measures typically assess
hypothesised determinants of behaviours, such as attitudes or intentions. There is good evidence
that asking people to complete these kinds of measures can affect behaviour11 and also that asking
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people to complete measures regarding their beliefs about behaviour can stimulate the creation of
new beliefs.93 For all these reasons, it may be particularly helpful to avoid process or interim measures,
or to design them optimally to reduce MR effects.
Recommendation 10: embed measurement procedures into routine clinical practice
when possible
The use of unobtrusive measures has long been recommended to avoid problems of measurement
affecting participants in research studies.94 Similarly, in the present context, it will often be desirable to
use measurements that are not collected primarily for research purposes, for example data in routine
health records or existing data collected for other purposes (e.g. national surveys). Because measurement
in trials is a potential source of bias due to MR, this threat is minimised when information from routinely
collected data is used instead. However, the use of routinely collected data does require scrutiny
regarding potential measurement error and/or how well the measures have been defined.
Recommendation 11: use identical measurement protocols in all arms of a trial
In line with established good practice for trial design, it is desirable to ensure that all aspects of
measurement procedures are identical across all arms of a trial. This involves ensuring that all
measurements are completed in the same setting at the same frequency and time points and, when
relevant, by the same types of people (e.g. research nurses or general practitioners). Format and
methodology should also be identical (e.g. online or pencil and paper questionnaire, semistructured
interviews). As described in Chapter 2, unbalanced measurement protocols are an a priori cause
indicator of a risk of bias from MR. Again, it is important to clearly distinguish between measurements
that are a component of the intervention and those that are for only evaluative purposes (see
Recommendation 1: consider potential for measurement reactivity causing bias at the design stage of a trial).
Sometimes differential measurement procedures across arms of a trial are employed to help address the
research question (e.g. to monitor physiological effects in only the intervention group).95,96 Researchers
in these types of studies should consider whether or not this difference in measurement procedures is
a problem and whether or not the control group might be asked to also complete the same measures.
This may have the additional benefit of blinding trial participants to the experimental condition to which
they have been randomised.
In some cases it would be unwise to give the control group the same measures. For example, if the
measurement procedures are a component of the intervention, participants in the control group will
necessarily receive part of the intervention. It is also the case that giving any participants measures
that are expected to have an effect on the trial outcome is generally undesirable because it may
produce bias towards null findings. In general, however, balanced measurement across conditions
introduces fewer problems than unbalanced measurement, although minimising any measurement is
usually the least problematic option.
Recommendation 12: avoid overlap between measurement and intervention
Some measurement techniques are similar, if not identical, to techniques that are designed to change
health-related behaviour (see Box 5 for a detailed discussion). For example, as noted earlier, the use
of pedometers to measure behaviour also appears to change behaviour. Pedometers are an efficient
method of allowing people to self-monitor their behaviour when the users are not blinded to outcome.
When such measurement techniques are used, there is the potential for bias as, in effect, both
experimental groups are receiving behaviour change interventions by virtue of the measurement
techniques employed. This raises the possibility of an underestimate of effect, especially when the
intervention includes the behaviour change technique (BCT) that the measurement technique mimics.
It is a clear threat to the validity of a trial if measurement techniques are used that closely resemble
the BCT that the trial is designed to evaluate. As part of the development of the logic model for the
intervention and MR effects, researchers may find it helpful to consider how the measurements may
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constitute active interventions. It may also be worth considering that measurement techniques that
mimic BCTs may also interact with other BCTs. For instance, the effects of risk communications are
much greater in the presence of interventions to increase self-efficacy.97 When the trial includes
measures of self-efficacy, if such measurement acts as an intervention to increase self-efficacy, it is
likely that this will synergistically interact with a risk communication intervention.
BOX 5 Detailed discussion of when measurement and intervention can overlap
A standardised taxonomy of BCTs16 identifies 93 distinct techniques for changing behaviour, and several
appear analogous to measurement procedures. For example, the following are a selection of BCTs and
definitions that the taxonomy includes, and which some measurement techniques directly mimic:
l monitoring of behaviour by others without feedback – observe or record behaviour with the person’s
knowledge as part of a behaviour change strategy
l biofeedback – provide feedback about the body (e.g. physiological or biochemical state) using an
external monitoring device as part of a behaviour change strategy
l monitoring of emotional consequences – prompt assessment of feelings after attempts at performing
the behaviour.
In addition, some other measurement approaches have many similarities to BCTs even if they do not
directly mimic them. The following are again a selection:
l information about health consequences – provide information (e.g. written, verbal, visual) about health
consequences of performing the behaviour
l focus on past success – advice to think about or list previous successes in performing the behaviour
(or parts of it)
l prompts/cues – introduce or define environmental or social stimulus with the purpose of prompting or
cueing the behaviour.
The first of these BCTs (i.e. information about health consequences) could be mimicked by measurement
approaches that ask participants to respond about how likely they believe are various consequences of a
behaviour (e.g. smoking). Although these questions do not directly provide information, it is clear that
people infer information from questions they are asked because they expect questions to be relevant to
the issue being discussed. Questions asking about outcome expectancies have this property and these are
common in many social cognition models.
The second BCT (i.e. focus on past successes) could be mimicked by asking participants for their judgements
of whether or nor they are capable of performing a behaviour. Although such questions do not directly ask
for people to focus on past successes, people use information about past successes and failures to evaluate
their future likelihood of success. Questions asking about self-efficacy have this property and, again, this
construct is common in many models of behaviour change.
The third BCT (i.e. prompts/cues) could be mimicked by many repeated assessments, using ecological
momentary assessment designs. In these designs, questions about behaviour and its hypothesised precursors
are asked on a regular basis (often daily) over a period of weeks or months. Similarly, asking someone to wear
a piece of equipment, such as an accelerometer or ambulatory blood pressure monitor, could function as a
prompt to remind them that they have signed up for an intervention to change behaviours (i.e. physical
activity or medication adherence) that an intervention is trying to promote, or which may have an effect on
one or more outcomes of the trial.
BCT, behaviour change technique.
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Recommendation 13: consider the potential benefits of masking measures and/or
withholding feedback of measured values against ethical considerations
Withholding information about which health-related outcomes are being measured in a study could help
reduce the risk of MR and potential bias in research studies. For example, research participants might
supply blood samples for a study but not be informed which biological variables are being measured in
their blood. This could protect from risks associated with research participants changing their behaviour
(thoughts or emotions) as a result of their awareness of what is being measured (e.g. diabetes patients who
are not informed that their blood glucose is being measured may be less likely to change their medication
adherence, diet or physical activity than if they are aware that their blood glucose is being measured).
Another approach taken by some researchers to mask the measures of primary interest is to embed
them among other ‘filler’ questions in a questionnaire to frame the data collection task in such a way
that the research participant is not informed about the measures of most interest to the research
team.98 However, careful consideration of potential negative consequences of requiring participants to
complete additional questions is required. Therefore, seeking a trade-off of the pros and cons to this
approach is likely to be needed (see Recommendation 9: consider possible measurement reactivity when
determining the overall burden of measurement in a trial).
Withholding feedback to research participants about measured values (e.g. 6 mmol/l of blood glucose)
could also help reduce the risk of MR and potential bias in research studies. Using the same example,
diabetes patients who are informed of their baseline fasting blood glucose values at the beginning of a
trial may modify their medication adherence, diet or physical activity on the basis of that knowledge.
These changes could interact with their response (or lack of it) to an intervention and consequently be
a source of bias. When such changes in behaviour are a risk, withholding disclosure of measured values
could reduce the risk of MR and bias.
In certain circumstances the aims of the research may be compromised by giving full information prior to
data collection. This is particularly pertinent when there is evidence of, or potential for, MR. For example,
there is evidence that covert sealed pedometers (described as ‘posture monitors’ to participants) do not
lead to MR (increased physical activity) in contrast to the use of an unsealed pedometer.13 It is recognised,
however, that masking of study measures has the potential to not only protect against MR but also induce
it. In the absence of information about a particular measurement, participants could come to their own
conclusions about the role of the measure in the study and change their behaviour, emotion or cognition
as a result.
Nevertheless, any participant information sheet given to a potential research participant needs to
include a clear statement of all aspects of a trial that are relevant to a participant’s decision to take part.
It is therefore imperative that ethical considerations are taken into account before any decisions on
masking of measurements (and potentially feedback of measured values) are made.99 Guidance on when
is appropriate to provide potentially inaccurate information in research studies has been provided by a
range of bodies, including the British Psychological Society.100 In brief, this British Psychological Society
report100 suggests that the amount of information withheld and the delay in disclosing the withheld
information should be kept to the absolute minimum necessary.When an essential element of the
research design would be compromised by full disclosure to participants, then the withholding of
information should be specified and appropriately justified in the project protocol, which should be
subjected to ethical review. In addition, explicit procedures should be stated to obviate any potential
harm arising from such withholding. According to the British Psychological Society, information should
be withheld or covert collection of data take place only if this is essential to achieve the research results
required. This could be interpreted as including a situation when research results are very likely to be
biased as a result of MR. It is imperative that the research objective has strong scientific merit and that
an appropriate risk management and harm alleviation strategy is in place. Similar guidance is given by
the Economic and Social Research Council.101 In line with existing guidance, it is important to provide
an appropriate debriefing for participants that later reveals the intention of the research, once data
collection is completed.
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Although masking of measures could be a potential technique for alleviating issues of MR, the issues to
consider are not limited to ethics. Participants decide to take part in research for a variety of reasons.
Some reasons are altruistic, but others may support participants’ own aims.102 For example, a participant
may want to be measured in some way to assess their own health status or to motivate them to achieve
a health-related target. As a result, decisions to take part in research may be dependent on the feedback
that participants receive. Masking measures and/or preventing feedback may therefore have a negative
impact on study recruitment and retention. Motivating factors for taking part in the research and the
role of measurements (and feedback) in the decision-making process are important topics to explore in
patient and public involvement initiatives in the early design stages of a trial.102,103
Recommendation 14: if measurement reactivity is likely to be present, investigations for
measurement reactivity should be included a priori in the statistical analysis plan
Ideally, evidence about the expected magnitude of MR is needed to inform analysis plans (see Chapter 5).
However, it may be difficult to distinguish bias due to MR from bias from other potential sources in a
trial at the statistical analysis stage. For instance, a statistician can explore how dilution bias may
manifest, but there are many sources of this type of bias, not just MR.
For many reasons, it is highly recommended that a statistical analysis plan be developed prior to the
analysis being carried out.104 Having considered the likelihood of MR in a particular trial based on logic,
external evidence and the recommendations provided in this document, if there is some reasonable
likelihood of MR being present, quantitative investigations of MR should be included a priori in the
trial protocol, including a statistical analysis plan. These investigations could include sensitivity analyses
based on, for example, a subgroup of trial participants measured more intensively in a qualitative
substudy in both trial arms. The sensitivity analysis could explore implications of adjusting for or
excluding those participants from the main quantitative analysis.
Statistical analyses should also be informed by feasibility and pilot work (see Recommendation 7: consider
whether or not measurement reactivity concerns for your trial warrant further empirical examination). For
example, for some measurement procedures (e.g. blood pressure or step count using pedometers) the
first one or two measurements are particularly reactive. Therefore, some researchers collect multiple
baseline measurements but do not use all of them.When researchers suspect that another measurement
procedure that they are using could be similarly reactive, then data from a feasibility trial could be
explored to look for MR in, for example, the first 1 or 2 days of measurement. If such MR appears to be
present, then data from these first 1 or 2 days could be removed from the main study analysis. However,
careful consideration of the potential negative consequences of requiring participants to complete
additional measurements is required.
When comparing multiple trials on a single intervention/topic in a systematic review, the reviewers
could consider MR as a source of heterogeneity, for example considering subgroups of trials based on
whether or not they had baseline measurement.
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Chapter 5 Future research
A major limitation of the evidence base used to develop the recommendations is the shortage ofgood-quality studies regarding the likely extent and magnitude of MR in many settings. There is a
particular lack of direct evidence regarding the extent to which MR produces bias in trials, despite a
good deal of speculation on this topic, including post hoc justifications for null trial effects.105 Examples
of prospectively designed studies that quantify bias are rare.106 The present section of this report
identifies the areas of research that should be prioritised to address this lack of evidence.
Recommendation 1: more primary research to quantify extent of
measurement reactivity
Some aspects of MR, such as the QBE, have received a considerable amount of research attention.9,10
This has produced estimates of the QBE as being of small magnitude, with considerable heterogeneity.
There is a need for further primary studies investigating the issue of MR more broadly than in relation
to the QBE, especially where there is a dearth of studies and where measures may be particularly
reactive. For example, there is a particular absence of evidence for dietary assessments, which can be
time-consuming and produce measures of healthy eating that are informative to research participants
and, hence, may promote more reflection regarding that behaviour. If such intensive measurements do
not produce compelling evidence of reactivity, then they are unlikely to lead to bias.
New primary research studies of MR should aim to have lower risk of bias than much research that
has been done to date.14 For example, many primary studies of the QBE have included confounders
such as thank you letters being sent in addition to questionnaires, which makes it unclear whether
any differences between experimental groups are because of a MR effect or because of the effects of
reminders or prompts.14 More recent studies of the QBE have been of higher quality (e.g. through
pre-registration of study protocols).
There is currently a dearth of research on potential for MR and implications for bias in clinical trials
that do not have a behavioural outcome, and future research in this area is particularly warranted.
Many trials of medical interventions involve closer, more intensive follow-up than would apply in
routine practice, which may be differential across trial arms. This may be justified for monitoring of the
safety of untested interventions or for measuring adherence; however, it could potentially alter the
results, making the present recommendations highly relevant.
There is also a shortage of studies specifically reporting the extent to which qualitative process
interviews or fidelity assessments are reactive. Although many trials have included these interviews
and assessments, the size of effect from such studies has not been reported. Furthermore, a priori
research protocols investigating the effects of interviews and assessments have generally not
been published.
Given the cost of trials, it may be most feasible for future studies that aim to quantify the extent
of MR to be SWATs.88 Such studies are nested within larger trials in which participants could be
randomised to receive different measurement procedures. Such procedures could involve the extent
of measurement (e.g. interim process measures or shorter questionnaires), the timing of measurement
(e.g. closer to vs. further away from intervention elements), the nature of outcome measurements
(e.g. objective vs. self-report) and the type of measurement procedures examined (e.g. questionnaire
vs. interview). Such SWATs should be pre-registered, with full reporting of all findings (including null
findings) on a range of primary and secondary trial outcomes. A particular problem in the MR literature
is that it is not clear whether the absence of evidence regarding reactivity is because of a lack of
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research activity or non-reporting of null findings.1 Such SWATs could also examine interacting effects
of measurement and the planned intervention, given the dearth of such research reported to date.23
A key consideration for any SWAT is that it should not detract from the key objectives of the main trial
within which the SWAT is nested. For example, when the impact of including quantitative measures of
hypothesised mediators is assessed, the study should still be powered to detect the hypothesised
mediation effect. Any variation in measurement could be statistically controlled for in the analyses of
the primary study. At the present time, it would generally be expected that measurement would have
only a small effect on outcomes1 and so it should not inflate sample sizes required for the main trial
purpose. It should be noted that future studies may produce evidence of larger MR effects than
the limited amount of previous research indicates. At this point, it may be useful to focus on the
psychological mechanisms underpinning how reactivity produces bias in trials, but this focus is
currently premature.
It may be sensible to employ adaptive designs107 whereby a SWAT is conducted to consider a specific
methodological issue (e.g. the effect of a set of measures on an outcome measure or primary outcome
response rate) until the evidence suggests that there is no effect of this experimental manipulation
and the trial can be continued without this experimental manipulation.
Recommendation 2: research priorities for studies within a trial
In general, the greatest need for evidence is where (1) there is a dearth of studies, (2) measures may
be particularly reactive and (3) the outcomes are particularly important. Other than this, three specific
areas identified as possible priorities for SWATs to further understanding of MR are as follows:
1. Table 4 shows the study features in which measurement may be more likely to be reactive and risk
bias. It would be useful for further empirical studies to provide more compelling evidence on these
study features.
2. The comparison of traditional obtrusive research methods with unobtrusive research methods. It
was proposed some time ago that being observed affects the behaviour of people being observed or
taking part in research studies. This is often known as the Hawthorne effect.6 There is still little
evidence on this subject relating to MR6 and there are ethical issues associated with masking and
other approaches that seek to be unobtrusive that need to be explored.
3. Effects on both objective and subjective outcomes. It is still not clear how far, and in which
circumstances, reactivity produces genuine changes in behaviour or just a mental recalibration of
how people think about behaviour.108 Although both a real change in behaviour and a recalibration
are of interest, the mechanisms and implications would be different and so clarity is needed on
this point.
Recommendation 3: more systematic reviewing to quantify extent and
variability of measurement reactivity
In addition to the conduct of further primary research it would also be helpful to summarise more
robustly the state of several current literatures. For example, the rapid systematic reviews conducted
for the present study indicate that there are several studies that have examined the impact of
objective measurement instruments (whether blinded or not) on physical activity. Other possible topics
include more formal reviews of the elevation of anxiety scores on the first occasion of measurement.
Future reviews may determine that there are sufficient studies of the reactive effects of nested
interview studies or fidelity assessments in trials. It may also be useful to meta-synthesise qualitative
studies of the experience of completing measures in trials and views about such measures.
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One of the barriers to systematic reviews of the impact of measurement on outcomes concerns the
poor reporting of the nature and extent of measurement. Evidence syntheses of existing research
studies may require additional data on measurement within those studies. It is common for secondary
trial outcomes not to be reported.90 A corollary of this is that the measures completed by participants
are thereby not reported. It is usual for journal publications to mention only those measures for which
results are reported, rather than those which are completed. Future primary studies should fully report
all measures that participants were asked to complete (e.g. in line with the Template for Intervention
Description and Replication reporting of intended interventions in trials).109
If sufficient SWATs are undertaken, then the results should be collated in living systematic reviews to
inform researchers about where there is sufficient evidence to no longer investigate the reactive
effects of particular forms of measurement and where there is a need for further primary research.
Recommendation 4: the need to better theorise when and why
measurement reactivity is likely to occur
Several explanations for the presence of the QBE have been empirically examined,3,10,11 with some
receiving limited empirical support. Despite this, much of this research has relied on moderator
analyses within systematic reviews, and it is likely that many of the moderators anticipated will turn
out to be artefacts due to confounding of numerous features. This makes it difficult to identify the
precise factors that are responsible for the presence of larger MR effects.14 Relatedly, the amount of
variance explained by these moderators in health settings is typically very small,9 making them of little
practical use in predicting when MR is likely to occur.
To make better progress in understanding this phenomenon there is a need for better theorising
of why reactivity may be occurring, including when, where and how. Qualitative studies that are
nested within trials will be useful in producing insights into how people experience the process of trial
participation and the experience of measurement itself.86 Although qualitative studies may not be able
to detect automatic psychological processes among participants, they can make useful contributions
to knowledge even if they do not provide the full picture of mechanisms underlying measurement
reactions. Such studies may nonetheless provide the basis for important conceptual advances.
Such insights will be useful in generating logic models (see Chapter 4, Recommendation 4: theorise
potential measurement reactions as part of a logic model of how an intervention is intended to work) that
specify how measurement may produce changes in those people being measured. Qualitative studies
nested within trials are likely to generate hypotheses regarding the circumstances when MR is likely
to occur in health settings, which subsequent research could then test via experimental manipulations.
Such studies could include trial or health-care staff to investigate the extent to which any reactivity
is due to these staff behaving differently in the light of information from measurements completed,
rather than the research participants reacting to such measurements. As with quantitative SWATs,
qualitative studies with research participants or staff should be comparatively inexpensive to conduct.
Qualitative studies may also help identify some subgroups of participants that are more likely to react to
measurement, and purposive sampling could help to further study these groups. Qualitative research to
understand the reasons why MR occurs also has the advantage that it could help establish contextual
influences on reactivity and deepen appreciation of the ethical issues involved in procedures, such as
masking, that seek to minimise MR. Much existing research on MR has focused on understanding the
intraindividual processes that may be responsible for reactivity.3,11 Although useful, such research may
be less useful in identifying the features of specific trials that would be more likely to produce MR.
Furthermore, research on contextual influences on MR may more easily translate into what steps
should be taken to reduce the likelihood of MR occurring and producing bias.
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Appendix 2 Example of an interaction
between baseline measurement and an
intervention in a Solomon four-group design
The Solomon four-group design study allows identification of an interaction between a studyintervention and baseline assessment. This type of study was used to test the effectiveness of a
sexual health intervention on condom use in young people.23,110 Participants were upper secondary
school students in Norway (n = 2088) who were aged between 16 and 20 years. The intervention
was developed based on cognitive social learning theory and social influence theory, implemented in
classrooms and delivered by teachers in collaboration with peer educators. The four arms of the trial
received the following:
1. sexual health intervention and pre-test questionnaire
2. sexual health intervention and no pre-test questionnaire
3. no intervention (control) and pre-test questionnaire
4. no intervention (control) and no pre-test questionnaire.
The pre-test 80-item questionnaires were given out in class and completed at home in the month
(or two) preceding implementation of the intervention. The majority of the questions concerned sexual
behaviour. Follow-up measures of condom use were collected at 6 and 12 months. Study results included
reports of an interaction effect in a subgroup of 403 participants who had their first intercourse prior to
the study and who provided follow-up data after 6 months (Table 5). The study is limited in that it does
not clearly specify whether or not this subgroup analysis was pre-planned. Nevertheless, all three other
conditions were found to be distinct from the reference group of those who were pre-tested and
received the intervention [odds ratios for condom use at most recent intercourse were 0.31, 0.42 and
0.41 (p = 0.005) or less for each comparison].
The study authors postulated several possible explanations for the appearance of this interaction
effect. Participants who received the pre-test questionnaire and the intervention were most likely to
use condoms. As suggested by the study authors,110 completion of the pre-test questionnaire in the
month (or two) preceding the intervention may have made students more prepared for, or familiar
with, the content of the intervention than students who started the intervention unprepared. The
authors suggest that it is possible that answering all the questions in the pre-test made the students
reflect more on their own sexual behaviour and therefore made them more aware of the problems and
more receptive to the solutions discussed during the intervention, making the topic of the intervention
more relevant to them personally.
Otherwise, the results of this study indicate that the intervention itself did not have any impact on use
of condoms. In such circumstances it is clear that testing the effectiveness of this intervention in a
standard RCT, assuming baseline assessments on sexual health behaviour take place, could result in an
TABLE 5 Condom use at most recent intercourse in participants who had
their first intercourse prior to the study
Intervention
Pre assessment, n/N (%)
Yes No
Yes 51/73 (70) 21/49 (43)
No 76/148 (51) 69/133 (52)
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overestimation of the effectiveness of the intervention as a result of biases attributed to MR. The
implications of such biases have implications for health-care decision-making based on trial evidence.
It is conceivable that a sexual health intervention is rolled out on the basis of evidence of persuasive
effect sizes reported in a trial yet the intervention, at a policy level, proves to be ineffective because
the effectiveness of the intervention is dependent on an interaction with baseline assessments that
does not take place when the intervention is implemented in practice.
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Appendix 3 Search strategy for rapid
review of systematic reviews
PsycINFO
General search strategy
(review OR meta-analy*) AND (measure* OR assess*) AND reactiv* NOT c-reactive.
Specific search strategy
(review OR meta-analy*) AND (“question-behaviour” OR “question-behavior” OR “mere measurement”).
PubMed
General search strategy
(review[Title/Abstract] OR meta-analy*[Title/Abstract]) AND (measure*[Title/Abstract] OR assess*
[Title/Abstract]) AND reactiv*[Title/Abstract] NOT c-reactive[Title/Abstract].
Specific search strategy
(review[Title/Abstract] OR meta-analy*[Title/Abstract]) AND (“question-behaviour”[Title/Abstract] OR
“question-behavior”[Title/Abstract] OR “mere measurement”[Title/Abstract]).
Cochrane Database of Systematic Reviews
General search strategy
As for PsycINFO.
(Note that, in the general search for PsycINFO and PubMed, the term reactiv* led to the retrieval of
many irrelevant articles that referred to C-reactive protein. Therefore, the term NOT c-reactive was
added to exclude these articles.)
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Appendix 4 Overlap between four recent
reviews of the question–behaviour effect
Details of the papers included in four recent reviews of the
question–behaviour effect
For each paper, the review(s) in which the paper was included are indicated by numbers in square
brackets as follows: 1 = Rodrigues et al.;9 2 = Spangenberg et al.;3 3 =Wood et al.;10 and 4 =Wilding et al.11
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FIGURE 4 Venn diagram to show overlap between four recent reviews of the QBE.
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Appendix 5 Explanatory guide to support
Table 4
Participant selection
The target population for a trial may not be homogeneous in terms of propensity to exhibit reactivity
to measurement. Consequently, recruitment processes might influence the risk of bias from MR. In
general, studies with less restrictive eligibility criteria and studies that employ population- or registry-
based recruitment are likely to be at lower risk of bias from MR than studies that include volunteer
participants who may have particular motivations to engage with the trial, including the interventions
and trial measures. For example, participants with greater health awareness and knowledge (e.g. health
‘enthusiasts’ who are able to understand or interpret the meaning of study measures) might be more
likely to react to measurement.
Systematic reviews that have investigated the QBE have included some moderator analyses that
lend support to the idea that some population groups might be more prone to MR than others.9–11
Specifically, one systematic review11 reported significantly larger effect sizes for the QBE in studies
using student samples than in studies using health-care patients, school pupils, employees or other
samples. In addition, two further systematic reviews9,10 reported greater effect sizes for the QBE in
student participants than in non-student study participants.
Measurements
Features of health outcome of interest
Participants’ knowledge of the study research question, and therefore the health-related outcome
of interest, can predispose them to MR. For example, a question about extent of physical activity
may alert a study participant to the purpose of an intervention (i.e. to increase physical activity)
and, even in a non-intervention comparator group, lead to efforts to become more active. In some
cases, masking of measurements may be used to disguise the study aims from research participants
and therefore reduce the risk of MR. This was shown in a study of pedometer use55 in which study
participants were informed that they were wearing ‘posture monitors’ as a method of masking the
purpose of the device. The devices were then unmasked and participants were told to continue to
wear the pedometer knowing what it was. Mean daily step counts reported in the unmasked condition
(at 1 week) were significantly higher than those recorded in the masked condition (at 1 week). This
implied that participants wearing unmasked pedometers were more likely to change their behaviour
in response to measurement.
Evidence to support MR is heavily reliant on the literature on the QBE. Several systematic reviews
have been published that suggest a small but important QBE.3,9–11 These have all focused on health-
related behavioural outcomes. Accordingly, current knowledge suggests that trials with health-related
behaviours as outcomes of interest are most at risk of bias from MR. Although not investigated to the
same extent, there is also evidence that completing health-focused questionnaires increases anxiety,19
and so study outcomes related to anxiety are also likely to be at risk of bias from MR.
It is plausible that health-related outcomes with well-recognised social norms (e.g. body weight) might
be at greater risk of MR.77 Moderator analyses in a systematic review10 lend support to this (i.e. social
desirability influenced the magnitude of the QBE). More socially desirable behaviours were associated
with a larger effect size for the QBE.
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Whether a trial is focusing on improving health-promoting behaviours (such as physical activity, screening
attendance) or reducing risky health-related behaviours is also likely to influence the potential for MR.
One systematic review10 reported that effect sizes for studies targeting risky behaviours were significantly
smaller than for studies targeting health-promoting behaviours. Similarly, another systematic review9
reported the largest QBEs for dental flossing, physical activity and screening attendance, which are all
health-promoting behaviours. Findings from a systematic review of brief alcohol interventions8 also
support the idea that risky health behaviours are less likely to be affected by MR. There was no statistical
difference in daily or weekly alcohol consumption between groups receiving or not receiving questions on
drinking behaviour in brief alcohol intervention trials.
Follow-up
Studies in which a variable is measured at interim time points, even when the measurement is balanced
across groups, are at risk of MR bias, either directly if the results of measurements are disclosed or
indirectly through the process of measurement. For example, there is good evidence of effects on
behaviour when questionnaires assessing hypothesised social cognitive determinants of behaviour
are administered.9,11
The relationship between length of time between baseline and follow-up measurements and the
duration of potential reactivity to baseline measurements is also an important consideration. It is
possible that reactive effects of measurement are short term,56 that is people change their behaviour
in response to measurement when the measurement procedure or tool has ‘novelty value’, after which
behaviour gradually returns to normal. Similarly, there is evidence that subjective reports of thoughts,
feelings and behaviours are subject to an initial elevation bias20 whereby reports of outcomes decline
over time.
Systematic reviews of the QBE support the view that a longer time interval between baseline
measurement (questionnaires) and assessment of outcome is associated with a smaller QBE.10,11
Therefore, trials with a shorter follow-up period are at greater risk of bias from MR than those with
a longer follow-up period. Consequently, short-term MR is likely to be of little concern for studies with
a long follow-up of several months or years, even if present. However, there is likely to be grounds
for concern in a situation where measurement reactions go on for several days and follow-up
measurements are taken 1–2 weeks after baseline measurements.
Features of measurement procedures/tools
Equivalence of measurement procedures across trial arms
Concerns about MR are most acute when the process or content of measurement is not balanced
across the arms of a randomised trial. Any study in which measurement is unbalanced across trial
arms is potentially at risk of measurement bias. Unbalanced measurement often arises from a desire
to measure the impact of an intervention (e.g. use of a digital device intended to improve care) that is
evaluated in the context of an unblinded clinical trial.
An example of an unbalanced design at risk of MR would be a study investigating blood glucose
self-management that compares an intervention using a blood glucose measuring device with usual
care (i.e. no device). Such a study could include a self-completion measure intended to understand
how use of the device might lead to changes in care. The use of such a questionnaire in only the
intervention arm could draw attention to aspects of the intervention (how to make better use of the
device), which could affect subsequent behaviour and thus might lead to changes in outcomes arising
from the process of measurement.
Similarity between measurement and behaviour change techniques
Study measures that mimic other BCTs might enhance (or diminish) response to an intervention.
Some measurement techniques are similar, if not identical, to techniques that are designed to change
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health-related behaviour. For example, the use of pedometers to measure behaviour also appears to change
behaviour because when unsealed, they allow people to self-monitor their behaviour.12,13 A standardised
taxonomy of BCTs16 identifies 93 distinct techniques for changing behaviour and several, including
self-monitoring, appear analogous to measurement procedures. When such measurement techniques are
used, there is the potential for bias because, in effect, both experimental groups are receiving behaviour
change interventions by virtue of the measurement techniques employed (see Box 5).
Source of data
The collection of new data specifically for the purposes of conducting the study under consideration
is at greater risk of MR bias than use of existing data that were not collected primarily for research
purposes. Examples include data in routine health records or existing data collected for other purposes
(e.g. national health surveys, consumer purchasing data, transport usage data such as cycle counter
statistics). The use of unobtrusive measures has long been recommended to avoid problems of
measurement affecting participants in research studies. Similarly, the threat of bias due to MR is
minimised when information from routinely collected data is used instead of new data collected
specifically for the purposes of the trial.
Measurements open to subjectivity
Use of self-report measurements in a trial is more likely to lead to risk of MR. The act of completing a
self-report measure by a research participant provides information to the participant about the study’s
health-related variable(s) of interest (e.g. alcohol intake, smoking status). Furthermore, the measured
values are self-disclosed by the participant (e.g. 12 alcohol drinks per week, four cigarettes smoked per
day), and so the participant becomes aware of their own health status and may change their thoughts,
emotions or behaviour as a result. Systematic reviews support the idea that measuring hypothesised
determinants of behaviour can produces changes in that behaviour,9,11 and there is also evidence that
asking people questions about beliefs can prompt the formation of beliefs.93
This does not mean that all objective measures are without risk of bias fromMR.This depends on the
nature of the objective measure and whether or not research participants are aware of, and understand,
the health-related variables of interest and the measured values. Although it is an objective measure
of physical activity, using an unsealed pedometer as a measure of physical activity also provides the
participant with information about the health-related behaviour of interest (i.e. physical activity) and the
measured values are disclosed because the number of steps taken per day is visible on the device. The use
of unsealed pedometers is therefore subject to a high risk of MR. In other situations, objective measures of
health-related variables could be at low risk of MR. For example, blood samples can be taken to measure
blood cholesterol level. It is possible that how the blood sample is used to assess health is concealed from
the research participant (i.e. they know that blood is taken, but not that blood cholesterol is going to
be measured) and it is possible that measured values are not disclosed to the participant. In such
circumstances the risk of MR is likely to be low.
Studies that involve unobtrusive measurement of data, or use data collected without participant
awareness (possibly collected through electronic media) or using masked measurement techniques,
will generally be associated with lower risk of MR bias.
Disclosure of measured values to participants
The results of measurements conducted on research participants may or may not be disclosed (via
feedback) to those research participants. Receiving feedback about clinical measurements from a study
is important for some, if not many, participants. For example, people with diabetes welcome the results
of blood tests for blood glucose levels taken at intervals.111 Furthermore, there is also evidence that
study participants wearing sealed pedometers show lower daily step counts than participants with
unsealed pedometers.13 This implies that participants wearing unsealed pedometers are more likely to
change their behaviour in response to measurement.
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Potential for MR is greater when measured values are disclosed to research participants either at the time
of measurement or shortly afterwards. In the case of self-reported measures, these values are obviously
immediately available to the research participants as they produce them. Some objective measures
also have the potential for MR if disclosed, for example if a research participant receives feedback on
their body weight or their steps per day (from an unsealed pedometer). In some cases, feedback can be
deliberately withheld to reduce the risk of reactivity (e.g. use of a sealed pedometer).13 In considering the
potential effects of disclosure of research measurements to participants it is important to think about all
aspects of the research process and participants’ understanding and familiarity with the measured values.
As well as values disclosed during the trial, measured values disclosed during assessment of participants’
eligibility for taking part in a trial can have an impact (e.g. when study participants are selected based on
health status).
Burden of measurement task
The burden of a measurement task for a research participant is an important factor when considering
potential for MR and bias. In general, the more onerous a measurement task is for a research participant,
the more likely it is that they will change their emotions, thoughts or behaviour as a result. The time
commitment required of a research participant is likely to have an impact. For example, measurements
that require a person to travel to a health-care setting for an appointment may allow time for contemplation
about the measurement. Conversely, completion of a question on a mobile phone might barely interrupt
a person’s day and so there is little opportunity to think about the measurement. Similarly, measurement
tasks that require activities to be recorded (e.g. food diaries for recording daily body weight) can be
burdensome for research participants and may be more likely to lead to measurement reactions than
tasks that require little time and effort from participants.
Complexity of measurement task
In general, the more complex a measurement task is for a research participant, the more likely it is to
result in the participant changing their emotions, thoughts or behaviour. The amount of interaction
with research personnel can be thought of as a component of complexity of a measurement task.
Physiological measures taken in a clinic, for example, involve much more interaction with research
personnel than completion of a questionnaire at home. The physical requirements of a measurement
task can also influence potential for reactivity. For example, providing a urine sample is simpler than
taking part in a cardiorespiratory fitness test.
Measurement framed in terms of goals/targets
The wording of items in self-report questionnaires has the potential to inform participants about reference
ranges. For example, participants might be asked about their alcohol intake in terms of consuming > 14 units
or ≤ 14 units of alcohol per week. Such wording implicitly informs participants that 14 units per week is an
upper limit for recommended alcohol intake. The participant then, simply by completing the question, has
an impression of whether they are drinking above or below recommended levels and might change their
thoughts, emotions or behaviour as a result. Similarly, another factor potentially leading to inadvertent
setting of goals for study participants is through feedback of measured values. If, for example, a participant
receives feedback that their total blood cholesterol is 3.5 mmol/l and this falls within the normal range,
then the inclusion of the reference range provides information about health risk to study participants.
This has potential consequences for the participants’ health-related thoughts, emotions or behaviour.
Context
The context and the type of setting (e.g. clinic, community, online, at home) in which measurement takes
place are important variables for consideration. The setting often influences the amount and intensity of
participant interaction with research personnel during measurements.When possible, embedding study
measurement procedures onto routine clinical procedures is advantageous in terms of reducing the risk
of measurement reactions (see Chapter 4, Recommendation 10: embed measurement procedures into routine
clinical practice when possible). Systematic review evidence suggests that measurements taken in laboratory
settings are more likely to lead to reactivity. One systematic review11 reported that laboratory-based QBE
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studies produced the largest overall effect on cognitions or behaviour and that the effect size was
significantly greater than those observed in medical, community and online settings. Similarly, a further
systematic review10 reported the QBE to be significantly stronger in laboratory settings than in field
settings. It is important not only to consider the potential impact of context or setting of measurements
in all aspects of the trial but also, as previously discussed, to maintain consistency in methods employed
across trial arms.
Interventions and comparators
Nature of the intervention
Self-management and self-monitoring interventions are intended to change trial participant behaviour.
However, it is important that baseline or interim measurements collected during the trial do not
replicate the intervention, inadvertently delivering it to the control or comparison group. For example,
if a questionnaire repeatedly asks about consumption of ‘five a day’ fruit and vegetable intake then
this can convey a behavioural goal. Similarly, if participants are then repeatedly asked about their fruit
and vegetable intake, this can encourage self-monitoring of a behaviour that many participants may
previously have not devoted much attention to.
The dual use of measurement to track outcomes and to guide delivery of components of an intervention
is a circumstance in which bias from MR is likely to be a risk. For instance, the use of tracking or
self-monitoring data as an outcome and also a behavioural goal is likely to be problematic, as is using
self-weighing as an intervention component and also as a measurement procedure. It is important to
make a clear distinction between measurement procedures that are part of the intervention and those
used for evaluative purposes.
Blinding to arm allocation
Blinding is normally employed in trials to conceal trial arm allocation to reduce differential treatment
and assessment of participants. This enables assessment of patient outcomes to be completed without
knowledge of the treatment received. Blinding is especially important when subjective outcome
measures are employed.112
Most studies of behavioural interventions are open studies in which trial arm allocation cannot be
concealed. Lack of blinding may contribute to conditions in which MR can develop because of interactions
between measurements and interventions. For example, those participants in the intervention arm of
a trial may receive measurements of blood glucose or hypertension and receive feedback on these
measurements, potentially alongside a discussion with a nurse or other health-care professional,
which may increase motivation to take prescribed medicine or modify other health-related behaviours.
Process evaluation
Process evaluation in a trial focuses on evaluating the delivery of trial interventions.79 A process
evaluation may ask how interventions are delivered, what mechanisms account for intervention effects
and how external factors influence the delivery and impact of interventions. Process evaluations
typically employ mixed methods that combine qualitative and quantitative elements. These elements
may include quantitative measures of mechanism, qualitative interviews with trial participants or
fidelity assessments with those providing the intervention. Such assessments are often unbalanced
across trial arms and may contribute to bias by heightening participants’ awareness of research
participation and the objectives of a trial, with potential impact on trial outcome assessment. If process
evaluation measures are conducted in only one arm of the trial, then MR is more likely to cause bias,
because measurement procedures are no longer equivalent across trial arms.
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It is fairly common for a process evaluation to aim to assess mechanisms that account for intervention
effects (i.e. when specific measures are included to directly assess mechanisms of action of the primary
outcome, this creates a greater risk of bias from MR).9,11 Qualitative investigations can occur before
the collection of the primary outcome. Such investigations may be particularly likely to produce bias
because they are likely to be quite intensive and possibly more memorable to many research participants
than the intervention itself, especially for trials with minimal interventions. The overall amount of
measurement conducted as part of the process evaluation is also an important consideration. In line
with recommendation 9 (see Chapter 4, Recommendation 9: consider possible measurement reactivity when
determining the overall burden of measurement in a trial), from a perspective of MR bias, less measurement
in trials would be preferable. Therefore, process evaluations that involve extensive measurement of data
in all study participants are particularly prone to bias from MR.
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